MH - Access to Primary Care UI - D000092863 MN - N4.590.374.350.250 MN - N5.300.430.188 MS - The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive PRIMARY CARE. HN - 2023 BX - Accessibility of Primary Care BX - Accessible Primary Care FX - Primary Health Care MH - Acute Aortic Syndrome UI - D000094683 MN - C14.907.109.70 MS - A group of aortic diseases presented with acute chest pain. It commonly includes AORTIC DISSECTION; AORTIC INTRAMURAL HEMATOMA; PENETRATING ATHEROSCLEROTIC ULCER and sometimes aortic aneurysms. HN - 2023 MH - African People UI - D000094842 MN - M1.686.254 MS - People native to or inhabitants of AFRICA. HN - 2023 BX - Africans MH - Allergic Fungal Sinusitis UI - D000092562 MN - C1.150.703.40 MN - C1.748.43 MN - C1.748.749.134 MN - C8.460.692.752.134 MN - C8.674.28 MN - C8.730.43 MN - C8.730.749.134 MN - C9.603.692.752.134 MN - C20.543.480.680.38 MS - Fungal infection in the PARANASAL SINUSES characterized by common allergy respiratory symptoms, recurrent NASAL POLYPS and/or ASTHMA with buildup of allergic MUCIN. AN - coordinate with specific fungal infection HN - 2023 BX - Allergic Aspergillus Sinusitis BX - Allergic Fungal Rhinosinusitis BX - Sphenoid Allergic Fungal Sinusitis MH - Anabolic Androgenic Steroids UI - D000094343 MN - D6.472.334.851.968.250 MS - Synthetic, or human-made, variations of the male sex hormone testosterone often misused by athletes to enhance performance. HN - 2023; for ANABOLIC STEROID use TESTOSTERONE CONGENERS 2017-2022 BX - Anabolic Androgenic Steroid BX - Anabolic Steroid MH - Aneurysm, Aortic Arch UI - D000094626 MN - C14.907.55.239.125.250 MN - C14.907.109.139.125.250 MS - An abnormal balloon- or sac-like dilatation in the wall of the AORTIC ARCH. HN - 2023 BX - Aortic Arch Aneurysm MH - Aneurysm, Ascending Aorta UI - D000094625 MN - C14.907.55.239.125.500 MN - C14.907.109.139.125.500 MS - An abnormal balloon- or sac-like dilatation in the wall of the ASCENDING AORTA. AN - dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE HN - 2023 BX - AAA Ascending Aorta Aneurysm BX - Ascending Aorta Aneurysm BX - Ascending Aortic Aneurysm MH - Anticoagulation Bridge UI - D000095062 MN - E2.134.500 MS - A peri-operative bridge therapy procedure in patients with high risk THROMBOEMBOLIC events and the risk of bleeding. HN - 2023 BX - Anticoagulation Bridge Therapy MH - Antiglycation Agents UI - D000093744 MN - D27.505.519.182 MS - Compounds that reduce the non-enzymatic glycation of proteins, lipids, and nucleic acids AND thus reducing the formation of ADVANCED GLYCATION END-PRODUCTS. HN - 2023 BX - Anti-Advanced Glycation End-Products Agents BX - Anti-Glycant BX - Anti-Glycants BX - Anti-Glycating Agent BX - Anti-Glycating Agents BX - Anti-Glycation Agent BX - Anti-Glycation Agents BX - Anti-Glycative Agent BX - Anti-Glycative Agents BX - Antiglycant BX - Antiglycants BX - Antiglycating Agent BX - Antiglycating Agents BX - Antiglycation Agent BX - Antiglycative Agent BX - Antiglycative Agents MH - Antiracism UI - D000095026 MN - I1.880.604.473.700.250 MN - K1.752.566.479.830.750.250 MN - N3.706.437.700.500 MN - N5.350.958.750.500 MS - Beliefs, actions or intentions, and policies that oppose RACISM or discrimination based on RACE. HN - 2023 BX - Anti-Racism FX - Racism MH - Aortic Aneurysm, Thoracoabdominal UI - D000094624 MN - C14.907.55.239.75.500 MN - C14.907.109.139.75.500 MS - An abnormal balloon- or sac-like dilatation in the wall of ABDOMINAL AORTA at the aortic hiatus. AN - dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE HN - 2023; use AORTIC ANEURYSM, THORACIC 2008-2022 BX - TAA Thoracoabdominal Aortic Aneurysm MH - Aortic Intramural Hematoma UI - D000094666 MN - C14.907.109.70.625 MN - C23.550.414.838.175 MS - An atypical form of AORTIC DISSECTION in which subintimal dissection of the aortic TUNICA MEDIA without initial laceration of the aortic TUNICA INTIMA. It may begin from a rupture of the VASA VASORUM feeding aortic media. HN - 2023 BX - Intramural Hematoma Aorta MH - Aortic Root Aneurysm UI - D000094628 MN - C14.907.55.239.125.375 MN - C14.907.109.139.125.375 MS - An abnormal balloon- or sac-like dilatation in the wall of the AORTIC ROOT. AN - dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE HN - 2023 BX - Aneurysm, Aortic Root MH - Apical Hypertrophic Cardiomyopathy UI - D000092183 MN - C14.280.195.400.500 MN - C14.280.238.100.250 MS - A hypertrophic cardiomyopathy characterized by apical hypertrophy, typically LEFT VENTRICULAR HYPERTROPHY (described as "ace of spades" sign), and deep T-wave inversions in EKG. Clinical symptoms include minor symptoms such as CHEST PAIN; DYSPNEA; and SYNCOPE to more complex symptoms such as ATRIAL FIBRILLATION; VENTRICULAR FIBRILLATION; MYOCARDIAL INFARCTION and CONGESTIVE HEART FAILURE. A transient left ventricular apical hypertrophy is sometimes associated with TAKOTSUBO CARDIOMYOPATHY. HN - 2023 BX - Apical-Variant HCM BX - Left Ventricular Apical Hypertrophic Cardiomyopathy MH - Artificial Life UI - D000092003 MN - H1.158.273.904.500 MN - H1.770.644.81 MS - Research involving the synthesis of life and life-like phenomena and the application of such techniques toward the enhancement of our theoretical understanding of life and life-like phenomena, studied through the use of computer programs. HN - 2023 MH - Asia, Southern UI - D000095143 MN - Z1.252.245.782 MS - The geographical designation for the countries of AFGHANISTAN; BANGLADESH; BHUTAN; INDIA; MALDIVES; NEPAL; PAKISTAN; and SRI LANKA. HN - 2023(1983); for BRITISH INDIAN OCEAN TERRITORY use AFRICA, EASTERN 1983-2022 BX - Asia, South BX - South Asia MH - Asian American Native Hawaiian and Pacific Islander UI - D000094202 MN - M1.270.906 MS - Members of Asian American, Native Hawaiian, and Pacific Islander community. HN - 2023 BX - AANHPI BX - Asian American Pacific Islander BX - Asian Americans Pacific Islanders MH - Australasian People UI - D000094861 MN - M1.686.493.500 MS - People native to or inhabitants of AUSTRALASIA including AUSTRALIA and NEW ZEALAND. HN - 2023 BX - Australasians MH - Axl Receptor Tyrosine Kinase UI - D000094963 MN - D8.811.913.696.620.682.725.400.975 MN - D12.776.476.568.400.975 MN - D12.776.543.750.630.875 MN - D12.776.624.664.700.13 MS - A member of the Tyro3-Axl-Mer (TAM) RECEPTOR PROTEIN-TYROSINE KINASES subfamily. Involved in several cellular functions including growth, migration, cell aggregation, and anti-inflammation. HN - 2023 (1999) MH - beta-D-Galactoside alpha 2-6-Sialyltransferase UI - D000094802 MN - D8.811.913.400.800.250 MS - Sialyltransferases that catalyze the transfer of N-ACETYLNEURAMINIC ACID from CYTIDINE MONOPHOSPHATE N-ACETYLNEURAMINIC ACID to the 6-OH of the GALACTOSE residue of N-GLYCANS. HN - 2023 BX - alpha 2-6-Sialyltransferase BX - alpha2,6(N) Sialyltransferase BX - alpha6-Sialyltransferase BX - beta-D-Galactoside alpha-2-6-Sialyltransferase BX - beta-Galactoside alpha2,6-Sialyltransferase BX - beta-Galactosyl(1-4)N-Acetylglucosaminide alpha(2-6)-Sialyltransferase BX - CMP-Acetylneuraminate Galactoside (alpha 2-6)-Sialyltransferase BX - CMP-N-Acetylneuraminate-beta-Galactoside alpha-2,6-Sialyltransferase BX - CMP-N-Acetylneuraminate-Galactosylglycoprotein Sialyltransferase ST6GAL BX - CMP-N-Acetylneuraminic Acid-Lactose Sialytransferase BX - CMP-NeuAc-Galactoside (alpha 2-6)-Sialyltransferase BX - CMP-Sialic Acid-N-Acetyllactosaminide alpha (2-6)-Sialyltransferase BX - Gal-1-4-GlcNAc alpha(2-6)-Sialyltransferase MH - beta-Galactoside alpha-2,3-Sialyltransferase UI - D000094663 MN - D8.811.913.400.800.500 MS - Sialyltransferases that catalyze the transfer of N-ACETYLNEURAMINIC ACID from CYTIDINE MONOPHOSPHATE N-ACETYLNEURAMINIC ACID to the 3-OH of the GALACTOSE residue of N-GLYCANS. HN - 2023 BX - alpha 2-3-Sialyltransferase BX - Asialofetuin Sialyltransferase BX - beta-D-Galactoside 3-alpha-Sialyltransferase BX - CMP N-Acetylneuraminate-beta-Galactoside alpha-2,3-Sialyltransferase BX - CMP-Acetylneuraminate-Galactoside (alpha 2-3)-Sialyltransferase BX - CMP-ANGS-Transferase BX - CMP-Neu5Ac-GAl beta1-3GalNAc alpha-2,3-Sialyltransferase BX - CMP-Neu5Ac-Gal1-3GalNAc alpha-2,3-Sialyltransferase BX - CMP-NeuAc-Galactoside (alpha 2-3)-Sialyltransferase BX - CMPSialic Acid beta-Galactosyl-1-3-N-Acetylgalactosaminide alpha 2-3-Sialyltransferase BX - Gal beta1,3GalNAc alpha2,3-Sialyltransferase MH - Betulinic Acid UI - D000094062 MN - D2.455.849.919.530.600.500 MS - A lupane-type triterpene derivative of betulin which was originally isolated from BETULA or birch tree. It has anti-inflammatory, anti-HIV and antineoplastic activities. HN - 2023 BX - 3-Epi-betulinic Acid BX - 3-Hydroxy-lup-20(29)-en-28-oic Acid BX - 3-Hydroxylup-20(29)-en-28-oic Acid BX - Betulic Acid MH - Bicornuate Uterus UI - D000093663 MN - C12.50.351.500.852.667.250 MS - A congenital uterine anomaly in which the UTERUS is divided into two uterine horns with a significant cleft at the uterine fundus due to partial fusion of the MULLERIAN DUCTS. Bicornuate uterus is sometimes associated with a longitudinal vaginal septum and abnormal development of renal tracts. HN - 2023 BX - Bicornuate Bicollis BX - Bicornuate Bicollis Uterus BX - Bicornuate Unicollis BX - Bicornuate Unicollis Uterus BX - Double Uterus and Longitudinal Vaginal Septum MH - Blood Banking UI - D000094902 MN - E2.792.833.230.250 MN - E5.760.833.230.250 MN - N2.421.911.50 MS - The administrative procedures and methods required for collecting, characterizing and storing blood or plasma in BLOOD BANKS. HN - 2023; use BLOOD BANKS 1966-2022 FX - Blood Banks FX - Blood Donation FX - Blood Preservation FX - Hematologic Tests MH - Blood Donation UI - D000094345 MN - N2.421.911.100 MS - Voluntary giving of BLOOD. HN - 2023; use BLOOD DONORS 1978-2022 BX - Blood Donating BX - Plasma Donation BX - Platelet Donation FX - Blood Banks FX - Blood Donors FX - Phlebotomy FX - Plasmapheresis FX - Plateletpheresis MH - Breakthrough Infections UI - D000093742 MN - C1.175 MN - C23.550.291.219 MS - Infections by the same infectious agent (e.g., virus, fungus) occurring during exposure to prophylaxis, vaccine and treatment. HN - 2023 BX - Treatment Emergent Infections BX - Vaccine Breakthrough Infections MH - Bridge Therapy UI - D000093142 MN - E2.134 MS - Treatment used in a transition between former and new therapeutic regimes. HN - 2023 MH - Bromodomain Containing Proteins UI - D000092468 MN - D12.776.660.235.25 MN - D12.776.664.235.25 MN - D12.776.930.900.100 MS - Non-histone chromosomal proteins that regulate GENE EXPRESSION through a variety of mechanisms including recognizing acetylated HISTONE LYSINE residues and through transcriptional machinery regulation. HN - 2023 (2001) BX - BRDs Containing Protein BX - Bromodomain-Containing Proteins MH - Bronchiolitis Obliterans Syndrome UI - D000092122 MN - C8.127.446.135.140.600.500 MN - C8.381.495.146.135.140.600.500 MN - C20.452.500 MS - Bronchiolitis obliterans complication from allogenic HEMATOPOIETIC STEM CELL TRANSPLANTATION and LUNG TRANSPLANTATION. HN - 2023 BX - BOS Bronchiolitis Obliterans Syndrome BX - Chronic Graft-Versus-Host Disease BX - Obstructive Chronic Lung Allograft Dysfunction BX - Obstructive CLAD MH - Calcinosis Cutis UI - D000092182 MN - C17.800.113 MN - C18.452.174.130.93 MS - Pathological deposition of calcium in the skin and subcutaneous tissue. Excessive calcification of the skin may be associated with underlying diseases that cause tissue damage (e.g., EHLERS-DANLOS SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME; and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g., CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS). HN - 2023 BX - Cutaneous Calcification BX - Dystrophic Calcinosis Cutis BX - Iatrogenic Calcinosis Cutis BX - Idiopathic Calcinosis Cutis BX - Metastatic Calcinosis Cutis MH - Capillary Isoelectric Focusing UI - D000094542 MN - E5.196.401.663.500 MN - E5.301.300.663.250 MS - Isoelectric focusing in capillary gels instead of slab gels. Capillary gel electrophoresis generally allows higher resolution, higher detection sensitivity and easier integration with other separation and detection techniques. HN - 2023 BX - CIEF Capillary Isoelectric Focusing BX - iCIEF BX - Imaged Capillary Isoelectric Focusing MH - Carbohydrate Binding Modules UI - D000094342 MN - G2.111.570.820.709.275.750.157 MS - Contiguous amino acid sequences within a carbohydrate-active enzyme with discrete folds having carbohydrate binding activity. They are classified into 43 different families based on AMINO ACID SEQUENCE, binding specificity, and structure. HN - 2023 BX - Carbohydrate Binding Module BX - Cellulose Bnding Domain BX - Chitin Binding Domain BX - Xylan Binding Domain MH - Caribbean People UI - D000094859 MN - M1.686.413 MS - People native to or inhabitants of islands in the Caribbean Sea or CARIBBEAN including ANTIGUA AND BARBUDA; ARUBA; BAHAMAS; BARBADOS; BRITISH VIRGIN ISLANDS; CARIBBEAN NETHERLANDS; CUBA; CURACAO; DOMINICA; DOMINICAN REPUBLIC; GRENADA; GUADELOUPE; HAITI; JAMAICA; MARTINIQUE; PUERTO RICO; SAINT KITTS AND NEVIS; SAINT LUCIA; SAINT VINCENT AND THE GRENADINES; SINT MAARTEN; TRINIDAD AND TOBAGO; and UNITED STATES VIRGIN ISLANDS. HN - 2023 BX - Caribbeans BX - West Indian People MH - Case Reports as Topic UI - D000094143 MN - L1.559.423.906.654.500 MS - Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis. HN - 2023 MH - Central African People UI - D000094845 MN - M1.686.254.750.500 MS - People native to or inhabitants of the CENTRAL AFRICA including CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; DEMOCRATIC REPUBLIC OF THE CONGO; EQUATORIAL GUINEA; GABON; and SAO TOME AND PRINCIPE. It includes indigenous peoples in the Congo Basin. Sometimes people native or inhabitants of the country of Central African Republic are referred to as Central Africans. HN - 2023 BX - Central African Person BX - Central Africans BX - Middle African People BX - Middle African Person BX - Middle Africans MH - Central American People UI - D000094866 MN - M1.686.429 MS - People native to or inhabitants of CENTRAL AMERICA including BELIZE; COSTA RICA; EL SALVADOR; GUATEMALA; HONDURAS; NICARAGUA; and PANAMA. HN - 2023 BX - Central American Person BX - Central Americans MH - Central Asian People UI - D000094850 MN - M1.686.330.375 MS - People native to or inhabitants of CENTRAL ASIA including KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN and UZBEKISTAN. HN - 2023 BX - Central Asian Person BX - Central Asians MH - Chronic Inducible Urticaria UI - D000094482 MN - C17.800.862.945.533.500 MN - C20.543.480.904.533.500 MN - C23.550.291.500.360.500 MS - Chronic urticaria with identified triggering factor which is either physical, e.g., vibratory urticaria, or non-physical, e.g., aquagenic urticaria. HN - 2023; use CHRONIC URTICARIA 2020-2022, for URTICARIA, AQUAGENIC use under UTTICARIA 2013-2022 BX - Aquagenic Urticaria BX - CIndU BX - Urticaria, Vibratory BX - Vibratory Urticaria MH - Chronic Kidney Diseases of Uncertain Etiology UI - D000092702 MN - C12.50.351.968.419.780.750.250 MN - C12.200.777.419.780.750.250 MN - C12.950.419.780.750.250 MN - C23.550.291.500.906.250 MN - C24.80.183 MS - Chronic kidney diseases not associated with traditional RISK FACTORS, e.g., TYPE 2 DIABETES MELLITUS and HYPERTENSION, but rather with infectious diseases, exposure to environmental toxins, or other unknown factors. They are most prevalent in agricultural communities of DEVELOPING COUNTRIES. HN - 2023 BX - Chronic Interstitial Nephritis of Agricultural Communities BX - Chronic Kidney Disease of Nontraditional Etiology BX - Chronic Kidney Disease of Uncertain Etiology BX - Chronic Kidney Disease of Unknown Etiology BX - Chronic Kidney Disease of Unknown or Uncertain Etiology BX - CINAC BX - CINAC Chronic Interstitial Nephritis in Agricultural Communities BX - CKD of Uncertain Etiology BX - CKDu Chronic Kidney Disease of Uncertain Etiology BX - CKDu Chronic Kidney Disease of Unknown Etiology BX - CKDu Chronic Kidney Diseases of Uncertain Etiology BX - KDUCAL BX - Kidney Disease of Unknown Cause in Agricultural Laborers BX - Mesoamerican Nephropathy MH - Chronotype UI - D000094407 MN - F1.752.227 MN - G7.180.562.190.500 MS - The natural inclination or preference of time of day in which an individual or an organism has the most activity, particularly as it relates to sleeping pattern and circadian sleep-wake preferences. HN - 2023 BX - Morningness Eveningness Preferences MH - Clinical Relevance UI - D000092522 MN - E1.55.500.500 MN - N4.761.559.590.399.125 MN - N5.715.360.575.575.399.125 MS - Criteria to determine whether a finding (e.g., clinical examination, lab test, imaging results) requires a medical intervention for meaningful improvement in outcome often to avoid OVERDIAGNOSIS and/or OVERTREATMENT. HN - 2023 BX - Clinical Importance BX - Clinical Significance FX - Confidence Intervals MH - Cognitive Training UI - D000091942 MN - E2.760.169.63.500.477.250 MN - E2.831.477.250 MN - H2.403.680.600.750.250 MN - N2.421.784.511.250 MS - A non-pharmacological form of treatment focusing on guided practice on tasks that target specific cognitive functions. These functions include memory, attention, and problem-solving. (from Cochrane.org/CD013069/DEMENTIA_cognitive-training-people-mild-moderate-dementia) HN - 2023 BX - Brain Training BX - Cognitive Rehabilitation MH - Collective Efficacy UI - D000092885 MN - F1.829.316.223.500 MN - F1.829.401.694.250 MN - I1.880.853.500.525.250 MN - N1.224.791.775.250 MN - N3.55.750.250 MN - N6.850.505.400.800.775.250 MS - A group belief and perception in its ability to complete a task successfully. It includes shared belief it can control deviant behavior of a member. HN - 2023 BX - Group Potency BX - Team Efficacy MH - Combat Medics UI - D000094767 MN - M1.526.373.250.500 MN - M1.526.485.67.150.500 MN - N2.360.67.150.500 MS - Individuals trained to provide medical care in a military operational or combat environment. HN - 2023 BX - Combat Medic BX - Combat Medical Technicians BX - Field Medical Service Technicians MH - Combined Antibody Therapeutics UI - D000094523 MN - D12.776.124.486.485.114.224.342 MN - D12.776.124.790.651.114.224.306 MN - D12.776.377.715.548.114.224.463 MN - D26.310.358 MS - Combinations of monoclonal antibodies used therapeutically to modulate the IMMUNE SYSTEM. HN - 2023 BX - Antibody Cocktail FX - Immunotherapy MH - Comprehensive Metabolic Panel UI - D000093182 MN - E1.370.225.124.100.174 MN - E5.200.124.100.174 MS - A series of blood tests on one panel that measure the body's chemical balance and metabolism. HN - 2023 BX - CMP Testing BX - Comprehensive Metabolic Panel Testing MH - Congenital Cranial Dysinnervation Disorders UI - D000093922 MN - C10.292.562.700.375 MN - C10.500.198 MN - C11.590.436.400 MN - C16.131.666.198 MS - Congenital neurodevelopmental diseases characterized by abnormal eye, eyelid, and facial movements. Congenital cranial dysinnervation disorders (CCDDs) are caused by abnormal innervation of CRANIAL NERVES (e.g., CNs III, IV and VI) resulting in aplasia or hypoplasia of the ocular and facial musculature involved in EYE MOVEMENTS. HN - 2023 BX - Congenital Cranial Dysinnervation Syndromes BX - Congenital Fibrosis Syndromes BX - Congenital Innervation Dysgenesis Syndrome MH - Corneal Cross-Linking UI - D000094504 MN - E2.186.500.500 MN - E2.319.685.500 MN - E2.774.722.218 MS - An ophthalmic treatment used to prevent weakening or bulging of the CORNEA in corneal ECTASIA, e.g., post-LASIK ectasia, KERATOCONUS and pellucid marginal corneal degeneration. It uses UV-A and RIBOFLAVIN to crosslink and strengthen COLLAGEN fibers within the cornea. HN - 2023 BX - Corneal Collagen Cross-Linking BX - Epi-off Corneal Cross-Linking BX - Epi-off CXL BX - Epi-on CXL BX - Epithelium-off Corneal Cross-Linking BX - Epithelium-off CXL BX - Epithelium-on Corneal Cross-Linking BX - Epithelium-on CXL BX - Transepithelial Corneal Cross-Linking BX - Transepithelial CXL MH - Correctional Facilities Personnel UI - D000093762 MN - M1.526.199 MS - Persons who work at JAILS; PRISONS; or other CORRECTIONAL INSTITUTIONS. HN - 2023 BX - Correctional Officers BX - Correctional Staff BX - Correctional Workers BX - Corrections Officers BX - Prison Guards MH - Cost-Effectiveness Analysis UI - D000094703 MN - N3.219.151.285 MS - A method of comparing the cost of a program with its expected outcomes that are qualitative in nature. Cost effectiveness compares alternative ways to achieve a specific set of results. HN - 2023; use COST-BENEFIT ANALYSIS 2015-2022 BX - Cost Effectiveness BX - Cost Effectiveness Ratio MH - COVID-19 Drug Treatment UI - D000093485 MN - E2.319.231 MS - The use of DRUGS to treat COVID19 or its symptoms. HN - 2023 (2020) BX - Coronavirus Disease 2019 Drug Treatment BX - Coronavirus Disease-19 Drug Treatment BX - COVID-19 Drug Therapy BX - COVID19 Drug Therapy BX - COVID19 Drug Treatment MH - COVID-19 Serotherapy UI - D000093522 MN - E2.95.465.425.400.330.50.200 MN - E5.478.550.520.50.200 MS - Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts. HN - 2023 (2020) BX - Convalescent Plasma Treatment for Covid-19 BX - Convalescent Serum Treatment for Covid-19 BX - Coronavirus Disease 2019 Serotherapy BX - Coronavirus Disease-19 Serotherapy BX - COVID-19 Convalescent Plasma Treatment BX - Covid-19 Convalescent Sera Treatment BX - COVID-19 Convalescent Serum Treatment BX - COVID-19 Hyperimmune Globulin Therapy BX - COVID-19 Serum Therapy BX - COVID19 Hyperimmune Globulin Therapy BX - COVID19 Serotherapy BX - COVID19 Serum Therapy BX - Hyperimmune Globulin Therapy for COVID-19 BX - SARS-CoV-2 Convalescent Plasma Treatment BX - SARS-CoV-2 Convalescent Sera Treatment BX - SARS-CoV-2 Convalescent Serum Treatment MH - Crystalluria UI - D000092162 MN - C23.888.942.169 MS - Crystals in the URINE found in urinary sediment analysis. Urinary crystalline may be formed from various metabolites (e.g., CALCIUM OXALATES; CALCIUM PHOSPHATES; URATES) and drugs (e.g., SULPHADIAZINE; ACYCLOVIR; and TRIAMTERENE). HN - 2023 FX - Urinary Calculi MH - Cyclin-Dependent Kinase-Activating Kinase UI - D000095043 MN - D8.811.913.696.620.682.700.646.500.992 MN - D12.776.167.200.790 MN - D12.776.476.563.646.500.992 MS - A highly-conserved cyclin-dependent kinase that activates other CYCLIN DEPENDENT KINASES and plays a key role in regulation of the CELL CYCLE. HN - 2023 (1990) BX - CDK-Activating Kinase BX - Cyclin Dependent Kinase Activating Kinase BX - P34CDC2 Activating Kinase MH - Cytology UI - D000093222 MN - H1.158.273.198 MN - H2.403.650.500.500 MS - The study of single cell as a unit of living organisms. Cytopathology, a branch of this discipline, studies structural changes of cells in diseases and is used in diagnosing diseases. AN - the discipline only (education, history, etc); for cytological structures use the qualifer /cytol with specific anatomical term or organism; for pathological structures use the qualifer /pathol with specific anatomical term HN - 2023 (1984) BX - Cytopathology MH - Delta Catenin UI - D000095002 MN - D12.776.220.145.875 MS - A CATENIN protein that plays a critical role in cell adhesion and tissue morphogenesis by regulating the surface stability of C-, E-, and N- CADHERINS. HN - 2023 (1994) BX - Cadherin-Associated Src Substrate p120 BX - Catenin Delta-1 BX - Catenin Delta-2 BX - Catenin p120(ctn) Protein BX - Catenin p120ctn Protein BX - Catenin, Delta BX - CTNND1 Protein BX - CTNND2 Protein BX - Delta Catenins BX - Delta-Catenin BX - Neurojungin MH - Dental Care Team UI - D000091982 MN - N4.590.715.275 MS - Care of dental patients by a multidisciplinary team usually organized under the leadership of a dentist; each member of the team has specific responsibilities and the whole team contributes to the oral care of the patient. HN - 2023 BX - Oral Care Team MH - Dental Enamel Hypomineralization UI - D000094603 MN - C7.650.800.295.500 MN - C7.793.700.295.500 MN - C16.131.850.800.295.500 MS - Reduced mineralization disorder of the DENTAL ENAMEL during development resulting in qualitative defects, e.g., discolored or chalky (soft) enamel. HN - 2023; for TOOTH HYPOMINERALIZATION see TOOTH DEMINERALIZATION 1992-2022; for MOLAR INCISOR HYPOMINERALIZATION use DENTAL ENAMEL HYPOPLASIA 1966-2022 BX - Dental Hypomineralization BX - Enamel Hypomineralization, Dental BX - Hypomineralization, Tooth BX - Tooth Hypomineralization MH - Descending Thoracic Aortic Aneurysm UI - D000094627 MN - C14.907.55.239.125.750 MN - C14.907.109.139.125.750 MS - An abnormal balloon- or sac-like dilatation in the wall of the DESCENDING THORACIC AORTA. AN - dissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE HN - 2023 BX - Aneurysm, Descending Thoracic Aorta MH - Developmental Defects of Enamel UI - D000094602 MN - C7.650.800.295 MN - C7.793.700.295 MN - C16.131.850.800.295 MS - Defects in normal AMELOGENESIS caused by any local, systemic, environmental, or genetic factors. Enamel defects resulting from demineralization of normally developed DENTAL ENAMEL is referred to as TOOTH DEMINERALIZATION. HN - 2023 BX - Developmental Dental Enamel Defects MH - Dietary Advanced Glycation End Products UI - D000093362 MN - D9.400.205.250 MN - D23.946.381.250 MN - G7.203.300.356 MN - J2.500.356 MS - Advanced glycation end products (AGEs) present in food. They are absorbed by the GASTROINTESTINAL SYSTEM and contribute to the body's total AGEs. The food BROWNING REACTION, such as occurs during food processing or cooking with high heat (frying, broiling, grilling, roasting, etc.) accelerates the formation of AGEs in food. HN - 2023 BX - Advanced Glycation End Product, Dietary BX - Advanced Glycation End Products, Dietary BX - Advanced Glycation Endproduct, Dietary BX - Advanced Glycation Endproducts, Dietary BX - Dietary Advanced Glycation End Product BX - Dietary Advanced Glycation Endproduct BX - Dietary Advanced Glycation Endproducts BX - Dietary AGE BX - Dietary AGEs BX - Dietary Maillard Reaction Product BX - Dietary Maillard Reaction Products BX - Maillard Reaction Product, Dietary BX - Maillard Reaction Products, Dietary MH - Dissection, Abdominal Aorta UI - D000094631 MN - C14.907.55.448.250.64 MN - C14.907.109.70.500.64 MS - Dissection or a tear of the ABDOMINAL AORTA. It includes thoracoabdominal aortic dissection at the aortic hiatus. HN - 2023 BX - Abdominal Aortic Dissection BX - Dissection, Thoracoabdominal Aorta BX - Thoracoabdominal Aortic Dissection MH - Dissection, Ascending Aorta UI - D000094630 MN - C14.907.55.448.250.128.500 MN - C14.907.109.70.500.128.500 HN - 2023 BX - Aortic Root Dissection BX - Ascending Aorta Dissection BX - Ascending Aortic Dissection BX - Dissection, Aortic Root MH - Dissection, Blood Vessel UI - D000094665 MN - C14.907.55.448 MS - A tear or separation of the layers by a blood vessel typically involving vessels under pressure, i.e., ARTERIES, e.g., AORTA. Tearing of the TUNICA INTIMA layer of a blood vessel may lead to interstitial HEMORRHAGE. Dissection between the tunica intima and TUNICA MEDIA causes luminal occlusion. Dissection at the media, or between the media and the outer ADVENTITIA causes aneurismal dilation. AN - coordinate with specific aneurysm term if available; otherwise coordinate with specific vessel or precoordinated vascular disease HN - 2023; use ANEURYSM, DISSECTING 2017-2022 BX - Arterial Dissection BX - Dissection Artery MH - Dissection, Thoracic Aorta UI - D000094629 MN - C14.907.55.448.250.128 MN - C14.907.109.70.500.128 MS - Dissection or a tear of the THORACIC AORTA. It includes aortic root dissection, ascending aortic dissection, aortic arch dissection and descending thoracic aortic dissection. HN - 2023 BX - Aortic Arch Dissection BX - Descending Aorta Dissection BX - Descending Thoracic Aortic Dissection BX - Dissection, Aortic Arch BX - Dissection, Descending Aorta BX - Dissection, Descending Thoracic Aorta BX - Thoracic Aorta Dissection BX - Thoracic Aortic Dissection MH - Diversity, Equity, Inclusion UI - D000092783 MN - I1.76.201.450.350.500 MN - I1.880.853.100.450.500 MS - Developing and ensuring compliance with laws, regulations, and policies that support civil rights, equity, diversity, and inclusion. Executive Order 13985 (Advancing Racial Equity and Support for Underserved Communities Through the Federal Government), which established that affirmatively advancing equity, civil rights, racial justice, and equal opportunity is the responsibility of the whole of our Government. HN - 2023 BX - Diversity, Equality, Inclusion BX - Diversity, Equality, Inclusion, Accessibility BX - Diversity, Equality, Inclusion, and Accessibility BX - Diversity, Equity, and Inclusiveness BX - Diversity, Equity, Inclusion, and Belonging BX - Diversity, Equity, Inclusion, Belonging BX - Diversity, Inclusion, Equity, and Belonging BX - Diversity, Inclusion, Equity, Belonging BX - Equity, Diversity, and Inclusion BX - Inclusion, Diversity, Equality, Accessibility MH - DNA Polymerase iota UI - D000094769 MN - D8.811.913.696.445.308.300.493 MS - A highly error-prone DNA polymerase. It is a member of the Y-family of DNA polymerases that are DNA DAMAGE tolerant and involved in translesion DNA synthesis. DNA polymerase iota is an orthologue of yeast Rad30. Its replication fidelity is template dependent and favors Hoogsteen base-pairing at its active site. HN - 2023 (2000) BX - POL iota BX - POLiota MH - Document Analysis UI - D000092002 MN - H1.770.644.241.850.375 MS - A form of qualitative research that uses a systematic procedure to analyze documentary evidence and answer specific research questions. HN - 2023 MH - Dopaminergic Imaging UI - D000092224 MN - E1.370.350.557.750 MN - E1.370.350.578.875.750 MN - E1.370.350.710.150 MN - E1.370.376.537.625.750 MN - E1.370.384.730.88 MN - E5.629.875.750 MS - Functional brain imaging techniques that utilize various RADIONUCLIDE TRACERS that bind to different targets in the SYNAPSES of DOPAMINERGIC NEURONS. HN - 2023 BX - DAT Imaging BX - Dopamine Receptor Imaging BX - Dopamine Transporter Imaging BX - Vesicular Monoamine Transporter Type 2 Imaging BX - VMAT2 Imaging MH - Dropped Head Syndrome UI - D000094222 MN - C5.651.515.500 MN - C10.597.613.593.500 MN - C23.550.695.500 MN - C23.888.592.608.593.500 MS - Condition characterized by sagging of the head due to severe NECK MUSCLES weakness in the back of the neck. It may result in severe cervical KYPHOSIS called chin-on-chest deformity. Dropped head syndrome is most often associated with other diseases, e.g., PARKINSON'S DISEASE; STROKES; HEAD AND NECK CANCER; and ANKYLOSING SPONDYLITIS. HN - 2023 BX - Chin-on-Chest Deformity MH - Drought Resistance UI - D000091902 MN - G15.150 MS - The ability of a plant to adapt in a drought environment and tolerate a reduction in available water. HN - 2023 BX - Drought Avoidence BX - Drought Escape BX - Drought Injury BX - Drought Recovery BX - Drought Tolerance FX - Droughts MH - Drug Fever UI - D000092582 MN - C20.543.418.257 MN - C23.888.119.344.173 MN - C25.100.468.690 MS - Drug-induced fever. HN - 2023 BX - Drug-Induced Fever BX - Drug-Induced Hyperthermia MH - Dust Mite Allergy UI - D000092542 MN - C8.460.799.315.500.500 MN - C8.674.453.500.500 MN - C9.603.799.315.500.500 MN - C20.543.480.680.443.500.500 MS - Allergic rhinitis due to HOUSE DUST MITE ALLERGENS (e.g., Der p 1 of HOUSE DUST MITES) that is triggered by the immune system. HN - 2023 BX - Dermatophagoides farinae Allergy BX - Dermatophagoides pteronyssinus Allergy BX - Dust Mite Hypersensitivity BX - House Dust Mite Allergy BX - House Dust Mite Hypersensitivity FX - Antigens, Dermatophagoides MH - East African People UI - D000094846 MN - M1.686.254.750.750 MS - People native to or inhabitants of EASTERN AFRICA including BURUNDI, DJIBOUTI, ERITREA, ETHIOPIA, KENYA, RWANDA, SOMALIA, SOUTH SUDAN, SUDAN, TANZANIA, and UGANDA and islands COMOROS; MADAGASCAR and SEYCHELLES. HN - 2023 BX - East African Person BX - East Africans BX - Eastern African People BX - Eastern African Person BX - Eastern Africans MH - East Asian People UI - D000095225 MN - M1.686.330.500 HN - 2023; for CHINESE use ASIANS 1981-2022, for JAPANESE use ASIANS 2004-2022; for KOREANS use ASIANS 2004-2022 BX - East Asians BX - Eastern Asian People BX - Eastern Asians BX - Far East Asians MH - Eastern European People UI - D000094855 MN - M1.686.445.500 MS - People native to or inhabitants of EASTERN EUROPE including ALBANIA; BOSNIA AND HERZEGOVINA; BULGARIA; CROATIA; CZECH REPUBLIC; ESTONIA; HUNGARY; KOSOVO; LATVIA; LITHUANIA; MOLDOVA; MONTENEGRO; POLAND; REPUBLIC OF NORTH MACEDONIA; REPUBLIC OF BELARUS; ROMANIA; RUSSIA; SERBIA; SLOVAKIA; SLOVENIA; and UKRAINE. HN - 2023 BX - East European People BX - East European Person BX - East Europeans BX - Eastern European Person BX - Eastern Europeans BX - Slavic People BX - Slavic Peoples MH - Ehlers-Danlos Syndrome, Type IV UI - D000094623 MN - C14.907.55.448.250.256 MN - C14.907.454.240.500 MN - C15.378.463.515.240.500 MN - C16.131.831.428.500 MN - C16.320.850.260.500 MN - C17.300.200.310.500 MN - C17.800.804.428.500 MN - C17.800.827.260.500 MS - A subtype of Ehlers-Danlos syndrome (EDS) characterized by vascular pathologies, e.g., AORTIC DISSECTION in addition to common EDS findings, e.g., hyperextensible skin and joints, skin fragility and reduced wound healing capability. It is associated with mutations in collagen type III alpha 1 chain gene (COLLAGEN TYPE III). HN - 2023; see EHLERS-DANLOS SYNDROME 2008-2022 BX - Type IV Ehlers-Danlos Syndrome BX - Vascular Ehlers-Danlos Syndrome BX - Vascular Type Ehlers-Danlos Syndrome MH - Elbow Fractures UI - D000092482 MN - C26.88.134.500 MN - C26.404.20 MS - Fractures of the distal HUMERUS and the proximal ULNA and the RADIUS at the ELBOW JOINT, including the head, anatomic and surgical necks, and tuberosities. HN - 2023 BX - Proximal Radial Fractures BX - Proximal Radius Fractures BX - Proximal Ulna Fractures MH - Elbow Injuries UI - D000092464 MN - C26.88.134 MS - Injuries involving the ELBOW and ELBOW JOINT. HN - 2023 BX - Elbow Joint Injuries MH - Electroporation Therapies UI - D000092722 MN - E2.348 MN - E5.200.500.454.750 MN - E5.242.448.750 MN - E5.301.500.750 MS - Treatment modalities that use pulsed electrical currents to permeabilize cell membranes and thereby enhance uptake of substances into cells of the body. HN - 2023 BX - Electroporation Therapeutic Uses BX - Electroporation Therapy BX - Therapeutic Use of Electroporation MH - Elimination Diets UI - D000092724 MN - G7.203.650.240.333 MS - Temporary dietary restrictions designed to help identify specific foods or FOOD ADDITIVES that trigger ALLERGIC REACTIONS, symptoms of DIGESTIVE SYSTEM DISORDERS, or other adverse food reactions. HN - 2023 BX - Diet, Elimination BX - Elimination Diet MH - Endovascular Aneurysm Repair UI - D000094682 MN - E4.100.814.529.953 MN - E4.100.814.868.500.500 MN - E4.502.382.953 MN - E4.650.200.500 MS - Endovascular surgery used to treat an AORTIC ANEURYSM. It involves implanting an endovascular stent graft around dilated vessel area reinforcing the wall and creating an artificial lumen through which blood can circulate bypassing aneurysm sac. HN - 2023 BX - BEVAR BX - Branched Endovascular Aneurysm Repair BX - Endovascular Aortic Repair BX - Endovascular Stent Grafting BX - Fenestrated Endovascular Aneurysm Repair BX - FEVAR BX - TEVAR BX - Thoracic Endovascular Aneurysm Repair BX - Thoracic Endovascular Aortic Repair MH - Epigenetic Memory UI - D000094363 MN - G5.308.203.280 MS - Various mechanisms by which a stable propagation of changes in gene expression that is passed from egg and sperm to the embryo persists via epigenetic changes, e.g., DNA METHYLATION pattern changes. HN - 2023 BX - Epigenetic Cellular Memory BX - Epigenetic Transcriptional Memory BX - Transgenerational Epigenetic Memory MH - European People UI - D000094854 MN - M1.686.445 MS - People native to or inhabitants of EUROPE. HN - 2023 BX - European Person BX - Europeans MH - Evidence Gaps UI - D000094505 MN - H1.770.644.264 MN - N3.349.380.105 MN - N5.425.171 MS - Areas where little or no evidence from impact evaluations and SYSTEMATIC REVIEWS is available and where future research should be focused (from https://openknowledge.worldbank.org/handle/10986/16941). AN - coordinate with specific field, disease, or topic if pertinent HN - 2023 BX - Evidence Practice Gaps BX - Insufficient Evidence BX - Research Gaps FX - Evidence-Based Practice MH - Exercise-Induced Allergies UI - D000092202 MN - C20.543.480.363 MS - Allergic reactions following a period of exercise. Elevated serum HISTAMINE and TRYPTASE levels and cutaneous MAST CELL degranulation are often associated with post-exertional allergic reactions which sometimes are triggered only in combination with prior consumption of a specific food such as wheat. Allergic symptoms produced post-exercise range from skin eruption, asthma, bronchospasm, and anaphylaxis. HN - 2023 BX - Exercise-Induced Anaphylaxis BX - Exercise-Induced Anaphylaxis and Urticaria BX - Exercise-Induced Urticaria BX - Food-Dependent Exercise-Induced Allergies BX - Post-Exertional Allergic Reactions BX - WDEIA BX - Wheat-Dependent Exercise-Induced Anaphylaxis FX - Vocal Cord Dysfunction MH - Extended Family UI - D000092842 MN - F1.829.263.315.250.125 MN - I1.240.361.330.500 MN - I1.880.853.150.423.250.125 MN - N1.224.361.330.500 MN - N1.824.308.125.500 MN - N6.850.505.400.400.580.500 MS - A household with members of at least three generations. HN - 2023; use FAMILY 1979-2022 BX - Extended Household BX - Multigenerational Family BX - Multigenerational Household MH - Family Structure UI - D000092822 MN - F1.829.263.315.250 MN - I1.240.361.330 MN - I1.880.761.125 MN - I1.880.853.150.423.250 MN - N1.224.361.330 MN - N1.824.308.125 MN - N6.850.505.400.400.580 MS - Structural nature of relationships among members of a household typically in reference to a MINOR residing in the same home. More broadly any organizational framework that determines family membership, and the functions and hierarchical position of family members (https://eric.ed.gov/?qt=Family+Structure&ti=Family+Structure). HN - 2023; for STEPFAMILY and FAMILY, RECONSTITUTED use FAMILY 1996-2022; for MATRIARCHY and PATRIARCHY use FAMILY CHARACTERISTICS 1995-2022 BX - Family, Reconstituted BX - Reconstituted Family BX - Step-parent Family BX - Stepfamily BX - Stepparent Family MH - Family Support UI - D000092802 MN - F1.829.263.370.82 MN - I1.880.853.150.439.500 MN - I1.880.853.500.600.375 MS - Support systems that provide assistance and encouragement between and among members of a FAMILY. HN - 2023 BX - Family Assistance BX - Family Encouragement MH - Femoral Fractures, Distal UI - D000092524 MN - C26.404.61.213 MN - C26.558.276.213 MS - Fractures of the distal FEMUR from the articular surface in the KNEE to the condylar region of the femur. A subset with a coronal-plane fracture of the distal femur condyle(s) is Hoffa Fracture. HN - 2023 BX - Distal Femoral Fractures BX - Distal Femur Fractures BX - Femur Fractures, Distal BX - Lateral Femoral Condyle Fractures BX - Medial Femoral Condyle Fractures MH - Fibula Fractures UI - D000092504 MN - C26.404.23 MS - Fractures of the FIBULA. HN - 2023 BX - Fibula Shaft Fractures BX - Maisonneuve Fracture BX - Maisonneuve Fracture Dislocation MH - Focal Cortical Dysplasia UI - D000092222 MN - C10.500.507.400.125 MN - C16.131.666.507.400.125 MS - Abnormal, non-neoplastic cell proliferation of the CEREBRAL CORTEX confined to an area in any lobe. Focal cortical dysplasia in the temporal lobe is associated with TEMPORAL LOBE EPILEPSY. HN - 2023 BX - Taylor Dysplasia BX - Taylor Focal Cortical Dysplasia BX - Taylor's FCD MH - FODMAP Diet UI - D000092622 MN - G7.203.650.240.333.500 MS - A type of elimination diet restricting from foods with fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, to help determine if specific foods containing these carbohydrates are triggering symptoms of IRRITABLE BOWEL SYNDROME. HN - 2023 BX - Diet, FODMAP BX - FODMAP-Containing Diet BX - FODMAPs Diet BX - Low FODMAP Diet BX - Low-FODMAP Diet MH - Food, Processed UI - D000092965 MN - G7.203.300.523 MN - J2.500.523 MS - Any raw agricultural commodity that has been subject to washing, cleaning, milling, cutting, chopping, heating, pasteurizing, blanching, cooking, canning, freezing, drying, dehydrating, mixing, packaging or other procedures that alter the food from its natural state. (from A Guide to Federal Terms and Acronyms. Lanham, MD: Government Institutes.1991) HN - 2023 BX - Food, Ultra-Processed BX - Processed Foods BX - Ultra-Processed Foods MH - Forensic Microbiology UI - D000095024 MN - I1.198.780.945 MS - The scientific discipline dedicated to analyzing evidence from BIOTERRORISM, biocrime, HOAX, or inadvertent microorganism/toxin release for attribution purposes. HN - 2023 BX - Forensic Microbial Science BX - Microbial Forensic Science BX - Microbial Forensics BX - Post Mortem Microbiology BX - Post-Mortem Microbiology BX - Postmortem Microbiology MH - Gasdermins UI - D000094524 MN - D12.776.157.530.400.353 MN - D12.776.543.550.450.464 MN - D12.776.543.585.400.464 MS - A family of pore-forming effector proteins that cause membrane permeabilization and PYROPTOSIS.. Gasdermin-induced pyroptosis plays a prominent role in many HEREDITARY DISEASES and autoinflammatory disorders as well as in CANCER. HN - 2023 BX - Cancer Associated Gasdermin-Domain Containing (GSDMDC) Proteins MH - Gemcitabine UI - D000093542 MN - D3.258 MN - D3.383.742.680.245.500.775 MS - A deoxycytidine antimetabolite used as an antineoplastic agent. HN - 2023 (1988) BX - 2',2'-Difluoro-2'-Deoxycytidine BX - 2',2'-Difluorodeoxycytidine BX - 2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate BX - 2'-Deoxy-2'-Difluorocytidine BX - Gemcitabine Hydrochloride BX - Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer BX - Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer BX - Gemcitabine, (D-threo-pentafuranosyl)-Isomer BX - Gemicitabine MH - Global Longitudinal Strain UI - D000094582 MN - G9.330.380.375 MS - Global longitudinal strain (GLS) is a measure of ventricular function derived from 2-dimensional echocardiographic images by quantifying the relative length change in myocardial length between end-diastole and end-systole. GLS is used to predict cardiovascular outcomes and has been proposed to be a better measure of cardiac dysfunction than VENTRICULAR EJECTION FRACTION. HN - 2023 BX - Left Ventricular Global Longitudinal Strain BX - LV-GLS BX - Right Ventricular Global Longitudinal Strain BX - RV-GLS MH - Glutathione Peroxidase GPX1 UI - D000094765 MN - D8.811.682.732.500.500 MN - D12.776.864.50.500 MS - One of the most abundant isoenzymes of the glutathione peroxidase family. Located in the cytosol and mitochondria, it catalyzes the reduction of HYDROGEN PEROXIDE to water, functioning to limit the accumulation of hydrogen peroxide and modulating processes that utilize hydrogen peroxide; and also the reduction of other organic hydroperoxides to their corresponding alcohols. HN - 2023 (1999) BX - Glutathione Peroxidase 1 BX - GPX1 Glutathione Peroxidase MH - Glycated Proteins UI - D000093844 MN - D9.400.205.625 MN - D9.400.430.914 MN - D12.776.395.351 MN - D12.776.794.375 MN - D23.946.381.625 MS - Advanced glycation end products formed from the spontaneous, non-enzymatic reaction of sugars with free amino groups in proteins. In the past, a glycosylated protein sometimes referred to a glycated protein. GLYCOSYLATED PROTEINS is now restricted to proteins glycosylated by GLYCOSYLTRANSFERASES or via specialized organic chemistry reactions. HN - 2023 MH - Glycated Serum Albumin UI - D000093423 MN - D9.400.205.625.500.500 MN - D9.400.430.914.500.500 MN - D12.776.34.841.113 MN - D12.776.124.335.500 MN - D12.776.124.727.188 MN - D12.776.395.351.500.500 MN - D23.946.381.625.500.500 MS - Serum albumin that has undergone, in vivo, spontaneous, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA. HN - 2023 BX - Glycated Albumin, Serum BX - Glycoalbumin BX - Glycosyl-Albumin BX - Glycosylated Serum Albumin BX - Serum Albumin, Glycosylated MH - Glycated Serum Proteins UI - D000093422 MN - D9.400.205.625.500 MN - D9.400.430.914.500 MN - D12.776.124.335 MN - D12.776.395.351.500 MN - D23.946.381.625.500 MS - Proteins in serum that have undergone, in vivo, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA. HN - 2023 BX - Glycated Blood Protein BX - Glycated Blood Proteins BX - Glycated Serum Protein BX - Glycosylated Blood Protein BX - Glycosylated Blood Proteins BX - Glycosylated Serum Protein BX - Glycosylated Serum Proteins BX - Serum Protein, Glycated BX - Serum Protein, Glycosylated MH - Group Dynamics UI - D000092923 MN - F1.829.316.223 MS - Processes of change in any social group from formation to functioning. It includes various forces that drive relationship among members and interaction with other groups. HN - 2023 BX - Group Interaction BX - Group Pressures BX - Groupthink BX - Organizational Behavior BX - Organizational Dynamics BX - Social Dynamics BX - Social Group Dynamics BX - Social Loafing MH - Gynecologists UI - D000094502 MN - M1.526.485.810.557 MN - N2.360.810.557 MS - Qualified medical professionals who specialize in GYNECOLOGY. HN - 2023 MH - Hippocampal Sclerosis UI - D000092223 MN - C10.500.507.400.187 MN - C16.131.666.507.400.187 MS - Neuronal loss in the hippocampal regions of CA1 and CA4 and less severely CA2 and CA3. Additional loss of hippocampal stratum radiatum, hippocampal atrophy and ASTROGLIOSIS are common. Hippocampal sclerosis is associated with intractable TEMPORAL LOBE EPILEPSY. HN - 2023 BX - Ammon Horn Sclerosis BX - CA1 Hippocampal Sclerosis BX - CA4 Hippocampal Sclerosis BX - Endfolium Sclerosis BX - Hippocampal Sclerosis of Aging BX - Mesial Temporal Sclerosis MH - Hoffa Fracture UI - D000092525 MN - C26.404.61.712 MN - C26.404.525.250 MN - C26.558.276.712 MN - C26.558.554.625.250 MS - Coronal plane fractures of the FEMUR condyle at the KNEE. HN - 2023 BX - Bicondylar Hoffa Fractures BX - Hoffa Fragment MH - Human Papillomavirus Viruses UI - D000094302 MN - B4.280.210.655.450 MN - B4.613.204.655.450 MS - A large group of viruses that cause HUMAN PAPILLOMAVIRUS INFECTION, e.g., GENITAL WARTS and cancer of the CERVIX; VAGINA; VULVA; ANUS; or OROPHARYNX. Most common clinically important human papilloma viruses are taxonomically members of ALPHAPAPILLOMAVIRUS and GAMMAPAPILLOMAVIRUS. AN - infection = HUMAN PAPILLOMAVIRUS INFECTION see PAPILLOMAVIRUS INFECTIONS HN - 2023; use ALPHAPAPILLOMAVIRUS 2016-2022 BX - HPV Human Papillomavirus BX - Human Papillomavirus MH - Humeral Fractures, Distal UI - D000092483 MN - C26.88.134.500.500 MN - C26.88.390.500 MN - C26.404.20.125 MN - C26.404.500.500 MS - Fractures of the distal HUMERUS at the ELBOW JOINT. HN - 2023 BX - Capitellum Humeri Fracture BX - Capitellum Humerus Fracture BX - Distal Humeral Fractures BX - Distal Humerus Fractures BX - Hahn-Steinthal Fracture BX - Humeral Capitellar Fractures BX - Humeral Trochlear Fractures BX - Intercondylar Humeral Fractures BX - Intercondylar Humerus Fractures BX - Kocher-Lorenz Fracture BX - Lateral Condylar Fracture of Humerus BX - Lateral Condylar Fractures of Humerus BX - Lateral Condyle Fracture of Humerus BX - Lateral Condyle Fractures of Humerus BX - Lateral Epicondylar Fracture of Humerus BX - Lateral Epicondylar Fractures of Humerus BX - Lateral Epicondyle Fracture of Humerus BX - Lateral Epicondyle Fractures of Humerus BX - Lateral Epicondyle Fractures of the Elbow BX - Lateral Humeral Condyle Fractures BX - Supracondylar Distal Humeral Fracture BX - Supracondylar Distal Humeral Fractures BX - Supracondylar Distal Humerus Fracture BX - Supracondylar Distal Humerus Fractures BX - Trochlear Fractures, Humerus MH - Hypothalamic-Pituitary-Gonadal Axis UI - D000094365 MN - A6.688.357.250 MN - A8.186.211.180.497.352.435.125 MN - A8.186.211.200.317.357.352.435.125 MN - A8.713.357.250 MS - A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS, the PITUITARY GLAND and the GONADS. It plays a central role in endocrine regulation of gonadal function including release of hormones: GNRH; LUTEINIZING HORMONE; FOLLICLE-STIMULATING HORMONE and TESTOSTERONE. HN - 2023 BX - HPG Axis BX - Hypothalamic-Pituitary-Gonadal Endocrine Axis MH - Idiopathic Noncirrhotic Portal Hypertension UI - D000094724 MN - C6.552.494.561 MS - Portal hypertension without known risk factors for hypertension, e.g., HEPATIC CIRRHOSIS and SCHISTOSOMIASIS. Idiopathic Noncirrhotic Portal Hypertension is most often associated with pathology in the PORTAL SYSTEM vasculature. HN - 2023 BX - Banti's Disease BX - Banti's Syndrome BX - Idiopathic Congestive Splenomegaly BX - Idiopathic Non-Cirrhotic Portal Hypertension BX - Idiopathic Portal Hypertension BX - INCPH BX - Noncirrhotic Portal Fibrosis BX - Porto-Sinusoidal Vascular Diseases MH - Immunonutrition Diet UI - D000093702 MN - G7.203.650.240.732 MS - Diets supplemented with nutrients that beneficially stimulate the IMMUNE RESPONSE and improve control of inflammatory processes. HN - 2023 BX - Immuno-Nutrition BX - Immunomodulating Diet BX - Immunomodulatory Diet BX - Immunonutrient-Enriched Diet BX - Immunonutrition MH - Infant, Large for Gestational Age UI - D000094522 MN - M1.60.703.520.230 MS - Infants whose BIRTH WEIGHT is larger than the 90th percentile for a given gestational age. AN - check the tag INFANT, NEWBORN; do not confuse with FETAL MACROSOMIA or INFANT, POSTMATURE HN - 2023 BX - High Birth Weight Infant BX - High-Birth-Weight Infant BX - Infant, Large-for-Gestational-Age BX - Large for Gestational Age Infant BX - Large-for-Gestational-Age Infant BX - LGA Infant MH - Information Motivation Behavioral Skills Model UI - D000092024 MN - E5.599.695.413 MS - A model for understanding patient behaviors, recognizes three constructs—information, motivation, and behavioral skills—needed to engage in a given health behavior, as specific individual determinants of behavior and behavioral change (Fisher & Fisher; Norton, 2009). HN - 2023 BX - Information-Motivation-Behavioral Skills Model MH - Information Sources UI - D000093983 MN - L1.462 MS - Various communications media, information centers, information services that are are utilized to obtain information. HN - 2023; for DATA SOURCES use INFORMATION STORAGE AND RETRIEVAL 1986-2022 BX - Data Source BX - Information Source BX - Source of Information BX - Sources of Information MH - Innate Immunity Recognition UI - D000094406 MN - G12.450.564.530 MS - Innate immunity systems which recognize presence of pathogens either through detection of damages associated with pathogen effector, e.g., pathogenic toxins and pore formation (effector triggered immunity) or though detection of molecular patterns common to many types of microbes (PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES) through PATTERN RECOGNITION RECEPTORS. HN - 2023 BX - Effector Triggered Immunity BX - Innate Immunity Recognition Systems BX - PAMP-Triggered Immunity BX - Pathogen-Associated Molecular Pattern-Triggered Immunity BX - Pattern-Triggered Immunity BX - Surveillance Immunity MH - Insulin Secretagogues UI - D000092005 MN - D27.505.696.422.625 MS - Hypoglycemic agents that stimulate INSULIN SECRETION from the PANCREATIC BETA CELL to decrease postprandial BLOOD GLUCOSE. HN - 2023 BX - Hypoglycemic Sulfonylureas BX - Insulin Secretogogue BX - Insulin Secretogogues BX - Meglitinide Analogues MH - Interferon Lambda UI - D000095022 MN - D12.644.276.374.440.946 MN - D12.776.467.374.440.946 MN - D23.529.374.440.946 MS - A specific type of interferon that is similar to INTERFERON TYPE I. It primarily functions at barrier epithelial surface, such as the respiratory tract and blood brain barrier HN - 2023 (2018) BX - IFN-Lambda BX - Interferon Type III BX - Interferon-Lambda BX - Lambda Interferons BX - Type III IFN BX - Type III IFNs BX - Type III Interferon BX - Type III Interferons MH - Interleukin-6 Inhibitors UI - D000093242 MN - D27.505.696.477.656.594 MS - Immunosuppressive agents which inhibit the action of INTERLEUKIN-6. HN - 2023 BX - Anti-IL-6 Agents BX - Anti-IL6 Agents BX - Anti-Interleukin-6 Agents BX - IL-6 Inhibitors BX - IL6 inhibitors MH - Intermittent Fasting UI - D000093763 MN - F1.145.407.400.500 MN - G7.203.650.240.587.500 MN - G7.203.650.353.400.500 MS - Alternating between fasting for an extended period of time during the day and eating during a restricted time for the day. HN - 2023; use FASTING 2019-2022; for TIME RESTRICTED FEEDING use FASTING 2019-2022 BX - Time Restricted Eating BX - Time Restricted Fasting MH - Irreversible Electroporation Therapy UI - D000092723 MN - E2.348.750 MN - E5.200.500.454.750.750 MN - E5.242.448.750.750 MN - E5.301.500.750.750 MS - The use of a dose of electricity that causes the pores that are formed in CELL MEMBRANES during ELECTROPORATION to remain open long enough to trigger CELL DEATH. It is sometimes used in conjunction with ELECTROCHEMOTHERAPY. HN - 2023 BX - Pulse Field Ablation MH - Isolated Systolic Hypertension UI - D000092244 MN - C14.907.489.165.500 MS - Hypertension with elevated systolic and normal diastolic blood pressure. It is the most common subtype in the elderly and is related to VASCULAR STIFFNESS and ATHEROSCLEROTIC PLAQUE buildup. HN - 2023 BX - Systolic Hypertension MH - Kinesiophobia UI - D000092442 MN - F1.100.575.500 MN - F1.470.132.225.500 MN - F3.80.725.375 MS - Anxiety disorder of persistent and irrational fear of movement following an injury. It is related to perceived disability due to injury and CATASTROPHIZING in fear of (anticipated) PAIN and possibility of REINJURY. HN - 2023 BX - Fear of Movement BX - Kinesophobia BX - Kinetophobia BX - Movement Phobia BX - Pain-Related Activity Avoidance BX - Phobia, Movement MH - Knee Fractures UI - D000092443 MN - C26.404.525 MN - C26.558.554.625 MS - Fractures of bones at the KNEE and the KNEE JOINT. HN - 2023 BX - Femoral Condyle Fractures BX - Femoral Condyles Fractures BX - Fractured Knee BX - Knee Joint Fractures BX - Tibial Eminence Fractures BX - Tibial Spine Fractures BX - Tibial Tuberosity Fractures MH - Lacticaseibacillus UI - D000093622 MN - B3.353.750.450.606 MN - B3.510.460.400.410.475.737 MN - B3.510.550.450.606 MS - A genus of gram-positive, non-motile, homofermentative, oxidase negative, rod-shaped bacteria occurring widely in nature. Its species previously were referred to as Lactobacillus casei group. The genus harbors several species that are used as starter cultures in dairy fermentations and as probiotics. HN - 2023 MH - Lagophthalmos UI - D000092164 MN - C11.300.750 MN - C11.338.714 MS - Inability to close eyelids completely. HN - 2023 BX - Blink Lagophthalmos BX - Cicatricial Lagophthalmos BX - Iatrogenic Lagophthalmos BX - Nocturnal Lagophthalmos BX - Paralytic Lagophthalmos MH - Layer-by-Layer Nanoparticles UI - D000093882 MN - J1.637.512.75 MS - Nanostructures fabricated by assembly of ordered layers of known compositions primarily through electro-static interactions. Such nanoparticles can be used for targeted delivery of complex components in ordered release patterns. HN - 2023 BX - Electrostatic Assembly Nanoparticles BX - Layer-by-Layer Assembly BX - Layer-by-Layer Assembly Nanoparticles BX - Layer-by-Layer Self-Assembly Nanoparticles BX - LbL Nanoparticles MH - Limbal Stem Cell Deficiency UI - D000092423 MN - C11.204.720 MS - Loss or disturbance of limbal STEM CELL function in the CORNEAL LIMBUS resulting in inability to self-renew CORNEAL EPITHELIUM and conjunctivalized corneal surface. HN - 2023 MH - Limbal Stem Cells UI - D000093282 MN - A11.872.40.750 MS - Adult somatic stem cells found in the basal epithelial layer of the LIMBUS CORNEAE. HN - 2023 BX - Corneal Epithelial Stem Cells BX - Limbal Epithelial Stem Cells of the Cornea MH - Local Field Potential Measurement UI - D000094382 MN - E1.370.376.400 MN - E1.370.405.353 MS - Recording of brain electrical activities recorded by a small-size electrode in the brain. It measures electric potential in the extracellular medium around neurons generated by small electric currents of local origin. HN - 2023 BX - Intracerebral LFP Measurement BX - Intracerebral Local Field Potential Measurement MH - Low Anterior Resection Syndrome UI - D000094123 MN - C6.405.469.158.644 MN - C6.405.469.860.512 MN - C23.550.767.550 MS - Postoperative complication after removal of the RECTUM (low anterior resection surgery or resection surgery to the lower part of the COLON). It includes disordered rectum function, e.g., frequent BOWEL MOVEMENT; FECAL INCONTINENCE; and CONSTIPATION. HN - 2023 MH - Low Socioeconomic Status UI - D000092886 MN - I1.880.853.996.755.337 MN - N1.824.782.337 MS - Socioeconomic status with relatively low income and/or assets (POVERTY) and EDUCATIONAL LEVEL. HN - 2023 BX - Low Socioeconomic Level MH - Lupanes UI - D000094042 MN - D2.455.849.919.530.600 MS - Pentacyclic triterpenes with isopropyl and its derivatives at the C19 position. It is initially biosynthesized by cyclization of oxidosqualene to lupeol. HN - 2023(2020) BX - Lupane Derivatives BX - Lupane Triterpenes BX - Lupane Triterpenoids BX - Lupane-Type Pentacyclic Triterpenoids BX - Lupane-Type Triterpenes BX - Lupane-Type Triterpenoids MH - Lymphocyte Activation Gene 3 Protein UI - D000093322 MN - D12.776.465.806 MN - D12.776.543.750.705.12 MN - D12.776.543.750.705.222.844 MN - D23.50.301.264.894.121 MN - D23.101.100.894.121 MS - A CD4-related protein with high affinity cell surface binding to MHC class II. It functions in downregulation of T cell proliferation following binding to MHC class II molecules. HN - 2023 (1992) BX - Antigens, CD223 BX - CD223 Antigen BX - Lymphocyte Activation Gene 3 Proteins FX - Lymphocyte Activation MH - Lysimachia UI - D000093782 MN - B1.875.800.575.912.250.341.984.690 MS - A plant genus of the family PRIMULACEAE. Lysimachia are used for herbal medicinal purposes. Common name loosestrife refers to members of Lysimachia (e.g., yellow loosestrife) and another plant family Lythrum (purple loosestrife). HN - 2023; use PRIMULACEAE 2004-2022 BX - Lysimachia vulgaris BX - Steironema BX - Yellow Loosestrife MH - M Cells UI - D000092303 MN - A10.615.550.522 MN - A11.436.578 MS - A distinct lineage of epithelial cells, present in MUCOSAL TISSUE, that is responsible for the immune sensing and capture of luminal bacteria and other microparticles. They deliver these microparticles, via TRANSCYTOSIS, to lymphoid tissue for efficient mucosal as well as systemic immune responses. Inflammation-induced M cells arising in response to inflammatory conditions may provide microbial access to tissues without normal M cell-associated immune surveillance tissue. HN - 2023 BX - Airway M Cells BX - BALT M Cells BX - Bronchiolar M Cells BX - Bronchus-Associated Lymphoid Tissue M Cells BX - Colonic M Cells BX - GALT M Cells BX - Gut-Associated Lymphoid Tissue M Cells BX - Intestinal Epithelial M cells BX - Intestinal Villous M Cells BX - M Cells, Bronchiolar BX - M Cells, Intestinal BX - MALT M Cells BX - Microfold Cells BX - Mucosa-Associated Lymphoid Tissue M Cells BX - NALT M Cells BX - Nasopharynx-Associated Lymphoid Tissue M Cells BX - Peyer's Patch M Cells BX - Tonsillar M Cells MH - Maldives UI - D000095164 MN - Z1.252.245.782.906 MS - Country in southern Asia, an island in the Indian Ocean. The capital is city of Male. HN - 2023; use INDIAN OCEAN ISLANDS 1978-2022 MH - Matrines UI - D000093842 MN - D3.132.722.500 MS - Tetracyclic bis-quinolizidine alkaloids found in the family LEGUMINOSAE, mainly in the genus SOPHORA. HN - 2023(1982) BX - Matrine BX - Matrine Alkaloids BX - Matrine, (5beta)-Isomer BX - Matrine-type Alkaloids BX - Sophoridine MH - MDA-MB-231 Cells UI - D000092302 MN - A11.251.210.190.660 MN - A11.251.860.180.630 MS - A human breast cancer cell line that was derived in 1973 from the MALIGNANT PLEURAL EFFUSION of a patient with stage III BREAST CARCINOMA and was characterized as being of breast cancer origin. HN - 2023 BX - MDA-MB-134 Breast Cancer Cells BX - MDA-MB-134 Breast Carcinoma Cells BX - MDA-MB-231 Cell Line MH - Medium Spiny Neurons UI - D000094242 MN - A8.675.289.500 MN - A8.675.650.535 MN - A11.671.285.500 MN - A11.671.650.535 MS - Medium sized, inhibitory GABAergic neurons in the CORPUS STRIATUM with highly developed dendritic trees. They are divided into neurons expressing DOPAMINE D1 RECEPTORS which project preferentially to the SUBSTANTIA NIGRA PARS RETICULATA and neurons expressing DOPAMINE D2 RECEPTORS which project preferentially to the lateral part of the GLOBUS PALLIDUS. Medium spiny neurons are preferentially lost in HUNTINGTON DISEASE. HN - 2023 BX - Striatal Medium-Sized Spiny Neurons FX - Corpus Striatum MH - Meibomitis UI - D000092663 MN - C11.338.133.500 MS - An inflammation of MEIBOMIAN GLANDS. HN - 2023 BX - Meibomianitis MH - Microphysiological Systems UI - D000094182 MN - A10.802.500 MN - E1.370.225.500.223.250.500 MN - E5.200.500.265.125.500 MN - E5.242.223.375.500 MN - E5.481.500.249.312.500 MN - E7.305.343.500.500 MS - Devices designed to recapitulate tissue or organ-level physiology and architect by combining MICROFLUIDICS; MICROFABRICATION; and 3D CELL CULTURE. Microphysiological systems mimic interconnections important in physiological or pathophysiological states of organ(s) and are often used for instance in HIGH THROUGHPUT SCREENING of drugs and factors important in disease modeling. HN - 2023 BX - Organ Chips BX - Organ-on-a-Chip BX - Organ-on-a-Chip Devices BX - Organoids-on-a-Chip BX - Organotypic Cell Cultures BX - Organotypic Cultures BX - Organotypic Models FX - Tissue Engineering MH - Middle Eastern and North Africans UI - D000094863 MN - M1.686.461 MS - People native to or inhabitants of the MIDDLE EAST and NORTH AFRICA. HN - 2023 BX - MENAs MH - Middle Eastern People UI - D000094864 MN - M1.686.330.875.250 MN - M1.686.461.250 MS - People native to or inhabitants of MIDDLE EAST including BAHRAIN; IRAN; IRAQ; ISRAEL; JORDAN; KUWAIT; LEBANON; OMAN; PALESTINIAN TERRITORIES; QATAR; SAUDI ARABIA; SYRIA; TURKEY; UNITED ARAB EMIRATES; and YEMEN. HN - 2023 BX - Middle Eastern Person BX - Middle Easterners BX - Near Easterners BX - Southwestern Asian People BX - Southwestern Asian Person BX - Southwestern Asians MH - Military Sexual Trauma UI - D000094964 MN - F3.950.750.438.500 MS - Physical and psychological injuries resulting from SEXUAL VIOLENCE during MILITARY service. HN - 2023 MH - Mixed Dementias UI - D000093902 MN - C10.228.140.380.711 MN - F3.615.400.756 MS - Dementias caused by multiple etiologies, e.g., ALZHEIMER DISEASE, and VASCULAR DEMENTIA and/or LEWY BODY DISEASE. HN - 2023 BX - Mixed-Etiology Dementias BX - Multiple-Etiology Dementias MH - Molar Hypomineralization UI - D000094604 MN - C7.650.800.295.500.750 MN - C7.793.700.295.500.750 MN - C16.131.850.800.295.500.750 MS - A type of developmental disturbance of AMELOGENESIS involving MOLARS of any type (obligatory) plus other teeth sometimes. It is characterized by demarcated enamel opacities with unknown systemic causation (idiopathic). HN - 2023; for MOLAR INCISOR HYPOMINERALIZATION use DENTAL ENAMEL HYPOPLASIA BX - Incisor Hypomineralization MH - Motion Capture UI - D000092682 MN - E1.370.395.500 MN - E5.613 MN - L1.280.960.200 MS - Technological process of recording the MOTION and MOVEMENT of objects (e.g., surgical instrument in robotic surgery), body parts (e.g., EYE MOVEMENT), animals or people. HN - 2023 BX - Biomechanical Movement Capture BX - Magnetic Motion Capture BX - MoCap Motion Capture BX - Optical Motion Capture FX - Motion Perception FX - Wearable Electronic Devices MH - Motorized Mobility Scooter UI - D000093102 MN - E7.796.980.500 MS - A device ridden while seated that usually has three or four wheels, is typically propelled by an electric motor, and is used by those with limited or impaired mobility. HN - 2023 BX - Motorized Scooter BX - Scooter Motorized MH - Multiomics UI - D000095028 MN - H1.158.273.180.650 MN - L1.313.124.500 MS - The study of a variety of omic data (TRANSCRIPTOME; PROTEOME; METABOLOME; etc.) generated from the same biological source such as a cell type or organ during normal versus diseased states. HN - 2023 BX - Multi-Omics MH - Multiple Amputations, Traumatic UI - D000092283 MN - C26.62.500 MS - The loss of part of, or all of, more than one limb, or other appendages of the body due to injury or disease. AN - by accident or injury; do not confuse with MULTIPLE AMPUTATION, SURGICAL (see AMPUTATION, SURGICAL), a surgical procedure; /surg: consider also REPLANTATION HN - 2023 BX - Amputations, Multiple, Traumatic BX - Multi-Limb Amputations, Traumatic BX - Multiple Extremity Amputations, Traumatic BX - Multiple Limb Amputations, Traumatic MH - Myotendinous Junction UI - D000094364 MN - A2.734 MS - A specialized interface between muscle and tendon through which most contractile force is transmitted. It consists of elaborate surface folding called interdigitations involving EXTRACELLULAR MATRIX and terminal SARCOMERES. HN - 2023 BX - Musculotendinous Junction MH - Navajo People UI - D000094684 MN - M1.270.968.500.600.531 MN - M1.686.477.250.600.531 MS - Southern Athabaskan-speaking Native American people generally associated with the Southwestern states. Navajo Nation is the largest Native American territory in the United States. HN - 2023 BX - Dine Navajo BX - Naabeeho People BX - Navaho People BX - Navajo Dine BX - Navajo Indians BX - Navajo Nation, Arizona, New Mexico, and Utah MH - Nerve Conduction Studies UI - D000092184 MN - E1.370.376.513 MN - E1.370.405.525 MS - Electrical tests to analyze the function of peripheral nerves by measuring various characteristics of NERVE CONDUCTION such as amplitude, velocity, and latency. HN - 2023 BX - Electroneurographic Studies BX - Electroneurography BX - F-Wave Recording, Electroneurographic BX - Nerve Conduction Tests BX - Nerve Conduction Velocity Studies BX - Nerve Conduction Velocity Tests MH - Nociceptin Receptor UI - D000094942 MN - D12.776.543.750.695.620.887 MN - D12.776.543.750.720.600.610.887 MN - D12.776.543.750.750.555.610.887 MS - A member of the opioid subfamily of the G PROTEIN-COUPLED RECEPTORS. It is the receptor for the endogenous neuropeptide nociceptin. It functions in modulating NOCICEPTION and the perception of pain. HN - 2023 (1996) BX - Kappa3-Related Opioid Receptor BX - KOR-3 Protein BX - MOR-C Protein BX - Nociceptin Receptors BX - OFQ Receptor BX - OFQ Receptors BX - Opiate Receptor-Like 1 BX - Opioid Receptor-Like Protein BX - Opioid-Receptor-Like 1 Protein BX - ORL1 Receptor BX - ORL1 Receptors BX - Orphanin FQ Receptor BX - Orphanin FQ Receptors BX - Receptor, Nociceptin BX - Receptor, OFQ BX - Receptor, Orphanin FQ BX - Receptors, ORL1 MH - Non-Muscle Invasive Bladder Neoplasms UI - D000093284 MN - C4.557.470.200.674 MN - C4.588.945.947.960.500 MN - C12.50.351.937.820.945.500 MN - C12.50.351.968.829.707.500 MN - C12.200.758.820.968.500 MN - C12.200.777.829.813.500 MN - C12.900.820.945.500 MN - C12.950.829.707.500 MN - C12.950.983.945.500 MS - A urothelial carcinoma found in the tissue that lines the inner surface of the bladder. The bladder muscle is not involved. HN - 2023 BX - NMIBC BX - Non-Muscle Invasive Bladder Cancer BX - Non-Muscle-Invasive Bladder Cancer MH - North African People UI - D000094843 MN - M1.686.254.500 MN - M1.686.461.500 MS - People native to or inhabitants of NORTH AFRICA including ALGERIA; EGYPT; LIBYA; MOROCCO; TUNISIA and the CANARY ISLANDS. HN - 2023 BX - Maghrebian People BX - Maghrebians BX - North African Person BX - North Africans BX - Northern African People BX - Northern African Person BX - Northern Africans MH - North American People UI - D000094858 MN - M1.686.477 MS - People native to or inhabitants of NORTH AMERICA. HN - 2023 BX - North American Person BX - North Americans MH - North Asian People UI - D000094852 MN - M1.686.330.625 MS - People native to or inhabitants of the NORTHERN ASIA including SIBERIA . HN - 2023 BX - North Asian Person BX - North Asians BX - Northern Asian People BX - Northern Asian Person BX - Northern Asians BX - Siberian People BX - Siberians MH - Obesity Paradox UI - D000094408 MN - E5.318.740.600.800.725.500.750 MN - N5.715.350.200.700.500.750 MN - N5.715.360.750.625.700.700.500.750 MN - N6.850.490.625.750.500.750 MN - N6.850.520.830.600.800.725.500.750 MS - An observation that high BODY MASS INDEX is sometimes associated with lower CARDIOVASCULAR DISEASE mortality in certain population, e.g., ELDERLY. HN - 2023 BX - BMI Paradox BX - Body Mass Index Paradox MH - Obstetricians UI - D000094503 MN - M1.526.485.810.664 MN - N2.360.810.664 MS - Qualified medical professionals who specialize in OBSTETRICS. HN - 2023 MH - Ocean Acidification UI - D000094404 MN - G16.500.777 MS - Reduction in OCEAN WATER overall pH. Ocean acidification is linked to CORAL BLEACHING and may disturb other marine BIODIVERSITY. HN - 2023 BX - Seawater Acidification MH - Oceanians UI - D000094862 MN - M1.686.493 MS - People native to or inhabitants of OCEANIA including MICRONESIA; MELANESIA; POLYNESIA; AUSTRALIA and NEW ZEALNAD. HN - 2023(2004) BX - Oceanian People BX - Oceanic Ancestry Group MH - Olecranon Fracture UI - D000092470 MN - C26.88.134.500.750 MN - C26.88.268.807.500 MN - C26.404.20.250 MN - C26.404.937.773 MS - Fractures of the OLECRANON PROCESS at the ELBOW JOINT. HN - 2023 BX - Fractures of the Olecranon Process BX - Olecranon Fractures BX - Olecranon Process Fracture BX - Olecranon Process Fractures MH - Olfactory Training UI - D000094562 MN - E2.662 MS - A non-surgical and non-pharmacological exercise treatment designed to manage OLFACTORY DISORDERS. HN - 2023 BX - Olfactory Rehabilitation BX - Smell Rehabilitation BX - Smell Training MH - Organizing Pneumonia UI - D000092124 MN - C8.127.446.135.140.600 MN - C8.381.495.146.135.140.600 MS - Any obstructive lung disease characterized by consolidated formation of GRANULATION TISSUE polyps within ALVEOLAR DUCTS AND ALVEOLI. It is classified as either primary (cryptogenic organizing pneumonia) or secondary organizing pneumonia. Secondary organizing pneumonia after transplantation is called bronchiolitis obliterans syndrome. HN - 2023 BX - Secondary Organizing Pneumonia MH - Overtraining Syndrome UI - D000095027 MN - C23.888.369.750 MS - An accumulation of training and/or non-training stress resulting in short-term decrement in performance capacity with or without related physiological and psychological signs and symptoms of maladaptation in which restoration of performance capacity may take from several weeks to several months.(from Curr Sports Med Rep. May-Jun 2015;14(3):157-8) HN - 2023 BX - Exercise Overtraining BX - Over-Training Syndrome MH - Pacific Island People UI - D000095188 MN - M1.686.493.500.800 MS - Persons having origins in any of PACIFIC ISLANDS. Note that OMB category NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. HN - 2023 BX - Melanesian People BX - Melanesians BX - Micronesian People BX - Micronesians BX - Pacific Islanders BX - Polynesian People BX - Polynesians MH - Pancreas Divisum UI - D000092142 MN - C6.198.947 MN - C6.689.388 MN - C16.131.314.667 MS - Anatomic variants in PANCREATIC DUCTS characterized by failure of fusion of the ventral and dorsal endodermal buds. Pancreas divisum results in inadequate or no communication between dorsal and ventral ducts. While most cases are asymptomatic, it may be associated with recurrent PANCREATITIS. HN - 2023 BX - Classic Pancreas Divisum BX - Classic Pancreatic Divisum BX - Complete Pancreas Divisum BX - Complete Pancreatic Divisum BX - Dominant Dorsal Duct Syndrome BX - Incomplete Pancreas Divisum BX - Incomplete Pancreatic Divisum BX - Inverted Pancreas Divisum BX - Pancreatic Divisum BX - Reverse Pancreas Divisum BX - Reverse Pancreatic Divisum MH - Paramedicine UI - D000094782 MN - H2.10.563 MS - A domain of practice and health profession that specialises across a range of settings including, but not limited to, emergency and primary care. Paramedics work in a variety of clinical settings such as EMERGENCY MEDICAL SERVICES, ambulance services, hospitals and clinics as well as non-clinical roles, such as education, leadership, public health and research. PARAMEDICS possess complex knowledge and skills, a broad scope of practice and are an essential part of the healthcare system. Depending on location, paramedics may practice under medical direction or independently, often in unscheduled, unpredictable or dynamic settings. (from J Multidiscip Healthc 2021 Dec 30;14:3561-3570) HN - 2023 BX - Community Paramedicine BX - Emergency Paramedicine FX - Community Health Services FX - Emergency Medical Technicians FX - Emergency Medicine FX - Paramedics MH - Paramedics UI - D000094783 MN - M1.526.373.575 MN - M1.526.485.67.718 MN - N2.360.67.715 MS - Health care workers who perform tasks which must otherwise be performed by a physician or other health professional, in a variety of clinical settings such as EMERGENCY MEDICAL SERVICES, ambulance services, hospitals and clinics as well as non-clinical roles, such as education, leadership, public health and research. Paramedics may practice under medical direction or independently, often in unscheduled, unpredictable or dynamic settings. HN - 2023; use ALLIED HEALTH PERSONNEL 1984-2022 BX - Community Paramedics BX - Emergency Paramedic BX - Emergency Paramedics BX - EMT-Paramedic BX - Paramedical Personnel BX - Paramedics, Emergency FX - Paramedicine MH - Partial Weight-Bearing UI - D000093002 MN - G1.374.965.500 MS - The state of supporting a body to simulate partial or applied load. HN - 2023 MH - Patella Fracture UI - D000092462 MN - C26.404.525.375 MS - Fractures of the PATELLA. HN - 2023 BX - Kneecap Fractures MH - Penetrating Atherosclerotic Ulcer UI - D000094667 MN - C14.907.109.70.750 MN - C14.907.137.126.834 MN - C14.907.613 MS - Ulceration of the AORTA by an ATHEROSCLEROTIC PLAQUE by penetrating through and disrupting the internal elastic lamina of the TUNICA INTIMA. HN - 2023 BX - Aortic Penetrating Ulcer BX - Penetrating Aortic Ulcer BX - Penetrating Ulcer BX - Penetrating Ulcer Aorta MH - Penile Transplantation UI - D000093667 MN - E4.936.450.825.750 MN - E4.936.864.850.750 MS - Surgical transference of the PENIS (or the PENIS and SCROTUM together) as a complete organ and the composite of many tissue types, from one individual to another. HN - 2023 BX - Penis Transplantation FX - Phalloplasty MH - Phalloplasty UI - D000093562 MN - E4.617.575 MS - Surgery to restore, reconstruct, or improve the shape or appearance of a damaged, misshapen, or missing PENIS due to injury, disease, or developmental abnormalities. HN - 2023 BX - Neophalloplasty BX - Reconstructive Penile Surgery BX - Reconstructive Penis Surgery FX - Penile Transplantation MH - Pharmacophore UI - D000092165 MN - E5.599.595.750 MS - A three-dimensional representation of a molecule that is used for modeling recognition of ligands and macromolecular targets. HN - 2023 BX - Pharmacophore Modeling MH - Phytoalexins UI - D000094162 MN - D23.946.618 MS - Secondary metabolites produced and accumulated by plants infected with microbial pathogen or otherwise under abiotic stress. Phytoalexins are structurally diverse but in common play a role in triggering PLANT SYSTEMIC ACQUIRED RESISTANCE. HN - 2023(1976) BX - Diterpenoid Phytoalexins BX - Flavonoid Phytoalexins BX - Indole Phytoalexins BX - Isoflavonoid Phytoalexins BX - Phytoalexin Metabolites BX - Sesquiterpene Phytoalexins BX - Terpenoid Phytoalexins FX - Secondary Metabolism MH - Phytosomes UI - D000094764 MN - D25.479.709 MN - D26.255.260.825 MN - J1.637.51.479.709 MN - J1.637.87.500.709 MS - Lipid-based vesicular drug delivery systems that are structurally related to LIPOSOMES. Unlike LIPOSOMES, PHYTOSOMES have their active ingredient as a part of their lipid membrane itself. HN - 2023 MH - Pima People UI - D000094685 MN - M1.270.968.500.600.687 MN - M1.686.477.250.600.687 MS - Oʼodham-speaking Native American people generally associated with Southwestern Arizona. HN - 2023 BX - Akimel O'odham People BX - Akimel O'otham BX - Akimel O'otham People BX - Pima Indians MH - Piwi-Interacting RNA UI - D000094322 MN - D13.150.650.700.500 MN - D13.444.735.150.700.500 MN - D13.444.735.790.552.875.500 MS - A class of small RNAs that are 24–31 nucleotides in length. They associate with the PIWI SUBFAMILY OF ARGONAUTE PROTEINS to form effector complexes known as piRNA-induced silencing complexes, which repress transposons via transcriptional or posttranscriptional mechanisms and maintain germline genome integrity. In addition to their role in transposon silencing, piRNAs in diverse organisms function in the regulation of cellular genes. HN - 2023; use RNA,SMALL INTERFERING 2008-2022 BX - piRNAs BX - RNA, Piwi-Interacting MH - Plant Systemic Acquired Resistance UI - D000094142 MN - G12.450.800.625 MN - G15.630.625 MS - A plant defense mechanism in which a plant pathogen-associated molecular pattern effector is detected through various receptors, e.g., PATTERN RECOGNITION RECEPTORS, which in turn induces fortified, primed defense in plant immune reaction. It confers long lasting and long distance plant immune defense against a broad spectrum of pathogens using various plant defense hormones or metabolites, e.g., SALICYLIC ACID and N-HYDROXYPIPECOLIC ACID, as signals to distant leaves for heightened immune state to counteract and limit subsequent infection. HN - 2023 BX - Induced Systemic Resistance BX - Systemic Acquired Resistance, Plant MH - Platypnea Orthodeoxia Syndrome UI - D000092129 MN - C8.618.326.698 MN - C23.888.852.79.898 MN - C23.888.852.371.698 MS - Orthostatic dyspnea and fall of oxygen blood saturation when standing up which regress by assuming lying position. HN - 2023 BX - Orthodeoxia BX - Platypnea-Orthodeoxia Syndrome BX - POS Platypnea Orthodeoxia Syndrome BX - POS Platypnea-Orthodeoxia Syndrome MH - Polyhydroxybutyrates UI - D000094122 MN - D5.750.78.789.500 MN - D5.750.728.890.500 MN - D10.751.500 MS - A thermostable biopolymer with repeating hydroxybutyryl units. It is typically the most abundant polyhydroxyalkanoate in microbes with PHA granules. HN - 2023 BX - 3-Hydroxybutanoic Acid Homopolymers BX - Poly(3-hydroxybutyrates) BX - Poly(hydroxybutyrates) MH - Polypoidal Choroidal Vasculopathy UI - D000092342 MN - C11.941.160.244.500 MN - C23.550.589.500.145.500 MS - A CHOROID neovascularization characterized by serosanguineous retinal pigment epithelial detachment and leakage of serous exudate sometimes associated with aneurysmal polypoidal lesions. HN - 2023 BX - Idiopathic Polypoidal Choroidal Vasculopathy BX - Polypoidal Choroidal Neovascularization BX - Polypoidal CNV MH - Popliteal Artery Aneurysm UI - D000094622 MN - C14.907.55.863 MS - An abnormal balloon- or sac-like dilatation in the wall of the POPLITEAL ARTERY located behind the KNEE JOINT. AN - dissecting aneurysm: coordinate with DISSECTION, BLOOD VESSEL; rupture: coordinate with ANEURYSM, RUPTURED HN - 2023 BX - Popliteal Aneurysm MH - Population Groups, US UI - D000095165 MN - M1.686.477.625 MS - Individuals classified according US federal government used for US federal data on race and ethnicity. Race and ethnicity terms are self-identified social construct. MeSH may contain outdated and offensive population terms only to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. HN - 2023 BX - US Population Groups MH - Post-Acute COVID-19 Syndrome UI - D000094024 MN - C1.748.610.763.500.500 MN - C1.925.705.500.500 MN - C1.925.782.600.550.200.163.500 MN - C8.381.677.807.500.500 MN - C8.730.610.763.500.500 MN - C23.550.291.500.829.375 MS - Post acute stage of COVID-19 virus infection. Persistent symptoms may include FATIGUE; DYSPNEA; and MEMORY LOSS. HN - 2023(2020) BX - Long COVID BX - Long Haul COVID-19 BX - Long-Haul COVID BX - Post Acute COVID-19 Syndrome BX - Post-Acute Sequelae of SARS-CoV-2 Infection BX - Post-COVID Conditions MH - Post-Infectious Disorders UI - D000094025 MN - C23.550.291.500.829 MS - Debilitating disorder characterized by fatigue and other symptoms related to cognitive, autonomous, and immune dysfunction experienced in the aftermath of infections. HN - 2023 BX - Post Active Phase of Infection Syndrome BX - Post Infectious Disorders BX - Post-Infection Syndrome BX - Post-Infectious Disease Syndrome MH - PPAR-gamma Agonists UI - D000092126 MN - D27.505.696.422.688 MS - Hypoglycemic agents that specifically target PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA. They increase tissue sensitivity to the insulin action and are used to treat TYPE 2 DIABETES MELLITUS. HN - 2023 BX - Peroxisome Proliferator-Activated Receptor-gamma Agonist BX - PPAR gamma Agonist BX - PPAR-gamma Agonist MH - Processing Speed UI - D000094725 MN - F2.463.188.817 MN - F2.808.430 MN - F2.830.628 MS - The time it takes to understand and do a mental task. Unlike REACTION TIME processing speed does not necessarily include a motor component in response. Processing speed is tested by most NEUROPSYCHOLOGICAL TESTS. HN - 2023 BX - Cognitive Processing Speed BX - Mental Processing Speed BX - Psychomotor Processing Speed BX - Psychomotor Speed MH - Prorenin Receptor UI - D000093342 MN - D8.811.277.40.25.325.813 MN - D8.811.913.696.650.150.500.813 MN - D12.776.157.530.450.250.875.500.813 MN - D12.776.543.585.450.250.875.500.813 MN - D12.776.543.750.608 MS - Single-pass transmembrane receptor protein that plays an important role in ANGIOTENSIN II production and cellular responses to RENIN. HN - 2023 (2002) BX - (Pro)renin Receptor BX - ATP6AP2 Protein BX - Receptor, Prorenin BX - Renin Receptor MH - Proteolysis Targeting Chimera UI - D000094243 MN - D27.720.470.410.210.500 MS - Bifunctional molecules that are designed to recruit E3 UBIQUITIN LIGASE to a specific target protein. Proteolysis targeting chimera consist of a target protein ligand connected via a linker to an E3 ligand. They promote association of E3 with specific target proteins tagged for degradation via the PROTEASOME. HN - 2023 BX - Cereblon-Based Small-Molecule Compounds BX - IAP-Based PROTACs BX - MDM2 Protein-Based PROTACs BX - Phospho-Dependent PROTACs BX - PhosphoPROTACs BX - PROTACs BX - VHL-Based PROTACs MH - Proteotoxic Stress UI - D000094403 MN - G3.818 MN - G7.775.782 MS - Stressors and conditions which disturb PROTEOSTASIS. Dysfunctional responses to proteotoxic stress are associated with CELL DEATH; CELL SENESCENCE;  CANCER and PROTEINOPATHY. HN - 2023 BX - Proteostasis Stress MH - Proximal Femoral Fractures UI - D000092526 MN - C26.404.61.425.500.500 MN - C26.404.61.856 MN - C26.531.750.500.500 MN - C26.558.276.425.500.500 MS - Fractures of the proximal FEMUR at the HIP. HN - 2023 BX - Femoral Fractures, Proximal BX - Femur Fractures, Proximal BX - Proximal Femur Fractures MH - Psychological Well-Being UI - D000092862 MN - F1.145.677.500 MN - I1.800.500 MN - K1.752.400.750.500 MN - N6.850.505.400.425.837.500 MS - Condition of existence, or state of awareness, in which psychological needs are satisfied HN - 2023 BX - Psychological Ill-Being BX - Psychological Wellness MH - Quinolizidine Alkaloids UI - D000093843 MN - D3.132.722 MN - D3.633.100.834.737.250 MS - Alkaloids containing QUINOLIZIDINE ring structure. They are found in the genistoid legumes of FABACEAE (formerly Leguminosae) including genera LUPINUS and SOPHORA. HN - 2023 BX - Lupin Quinolizidine Alkaloid BX - Lupin Quinolizidine Alkaloids BX - Lupine Quinolizidine Alkaloid BX - Lupine Quinolizidine Alkaloids BX - Quinolizidine Alkaloid MH - Radial Head and Neck Fractures UI - D000092467 MN - C26.88.134.500.875 MN - C26.88.268.556.500 MN - C26.404.20.500 MN - C26.404.562.678 MS - Fractures of the proximal head and/or neck of the RADIUS bone near the ELBOW JOINT. HN - 2023 BX - Fracture of Head of Radius BX - Fracture of Neck of Radius BX - Fractures of Head of Radius BX - Fractures of Neck of Radius BX - Radial Head Fractures BX - Radial Neck and Head Fractures BX - Radial Neck Fractures MH - Random Forest UI - D000093743 MN - G17.35.812 MN - G17.162.500.500 MN - G17.162.750 MN - L1.224.50.843 MS - An algorithm used in decision analysis and MACHINE LEARNING that uses a set of trees to combine output of multiple, randomly generated DECISION TREES. The final class of each tree is aggregated and evaluated by weighted values to construct the final classifier. HN - 2023 BX - Random Forest Algorithm BX - Random Forest Classification MH - Rapid Diagnostic Tests UI - D000092025 MN - E1.370.225.989 MN - E5.200.989 MN - N4.590.874.500.625 MS - Diagnostic assays designed for use at the point-of-care (POC) that can be adapted for use in low-resource settings. These tests are low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time. HN - 2023 BX - Rapid Diagnostic Test BX - Rapid Diagnostics MH - Renin Inhibitors UI - D000092502 MN - D27.505.519.389.745.753 MS - Agents that inhibit the activity of RENIN and cause VASODILATION. HN - 2023 BX - Direct Renin Inhibitor BX - Direct Renin Inhibitors BX - Renin Inhibitor MH - Residential Segregation UI - D000093863 MN - I1.880.735.820.750 MN - N1.224.791.775.375 MN - N6.850.505.400.800.775.375 MS - Spatial separation of HOUSING within a geographic area based on racial, ethnic, nationality and other SOCIOECONOMIC FACTORS. HN - 2023 BX - Gentrification BX - Neighborhood Ethnic Composition BX - Neighborhood Ethnic Racial Composition BX - Neighborhood Racial Composition BX - Neighborhood Racial Ethnic Composition MH - Resource-Limited Settings UI - D000092943 MN - N3.349.340.500 MN - N5.300.420.550 MS - Environments with barriers to quality critical care characterized by lack of epidemiological data and context-specific evidence for medical decision-making, deficiencies in health systems organization and resources, and institutional obstacles to implementation of life-saving interventions. HN - 2023 BX - Resource Limited Areas BX - Resource Limited Regions MH - Ribosome Profiling UI - D000094506 MN - E5.393.332.125 MN - E5.393.760.319.375 MN - E5.393.760.710.250 MS - A technique of mRNA sequence analysis that is used to determine which mRNAs are being actively translated. This technique relies on sequencing of RIBOSOME protected mRNA fragments (so-called ribosomal footprints) allowing the indication of the exact positions of ribosomes on transcripts. HN - 2023 BX - Ribo-Seq BX - Ribosome Footprinting BX - Ribosome-Bound tRNA Capture BX - Translating Ribosome Affinity Purification BX - Translation Profiling MH - Ribosome Shunting UI - D000094409 MN - G2.111.660.871.650.500 MN - G3.734.871.650.500 MN - G5.297.670.500 MN - G5.308.385.500 MS - Viral mechanisms of translational programming in which ribosomes reach the start codon bypassing or shunting over large segments of the 5′ UTR of VIRAL RNA. Ribosome shunting allows host translational machinery to engage polycistronic transcripts similar to RIBOSOMAL FRAMESHIFTING, and use of INTERNAL RIBOSOME ENTRY SITES. HN - 2023 BX - Ribosomal Shunting BX - Shunting, Ribosome MH - RNA Replication UI - D000094405 MN - G2.111.770 MN - G5.769 MN - G6.920.925.470 MS - The process by which a VIRAL RNA molecule is duplicated. AN - VIRUS REPLICATION is also available; consider also RNA, VIRAL /biosyn HN - 2023 FX - RNA-Dependent RNA Polymerase FX - RNA-Directed DNA Polymerase MH - RNA, Guide, CRISPR-Cas Systems UI - D000094704 MN - D13.444.735.790.552.563 MS - A component of CRISPR-Cas SYSTEMS. Cas endodeoxyribonucleases assemble with a guide RNA complex, a hybrid of CRISPR RNA (crRNA) and transactivating crRNA (tracrRNA) molecules, to form an active complex that cleaves DNA. crRNA and tracrRNA can be synthetically fused into a single RNA molecule, namely single guide RNA. Synthetic sgRNA is used with CRISPR-Cas SYSTEMS for targeted GENE EDITING. AN - do not confuse with RNA, GUIDE, KINETOPLASTIDA; do not confuse sgRNA (SINGLE-GUIDE RNA) with sgRNA (SUBGENOMIC RNA) HN - 2023 BX - CRISPR Guide RNA BX - CRISPR-Cas Systems sgRNA (Single Guide RNA) BX - crRNA BX - crRNA, Transactivating BX - Guide RNA (CRISPR-Cas Systems) BX - Guide RNA, CRISPR-Cas Systems BX - RNA, CRISPR Guide BX - RNA, Guide (CRISPR-Cas Systems) BX - RNA, Single Guide BX - RNA, Single-Guide BX - sgRNA (CRISPR-Cas Systems) BX - sgRNA (Single-Guide RNA) BX - Single Guide RNA BX - Single-Guide RNA BX - tracrRNA BX - Transactivating crRNA FX - CRISPR-Cas Systems MH - Scandinavians and Nordic People UI - D000094857 MN - M1.686.445.750 MS - People native to or inhabitants of the SCANDINAVIAN AND NORDIC COUNTRIES. HN - 2023 BX - Nordic People BX - Scandinavian People BX - Scandinavians MH - Schaffer Collaterals UI - D000094282 MN - A8.186.211.180.405.800 MN - A8.186.211.200.885.287.500.345.800 MN - A8.675.542.145.875 MN - A11.284.180.75.624 MN - A11.671.501.145.875 MS - The main axon connection from the CA3 PYRAMIDAL CELL AREA to the CA1 PYRAMIDAL CELL AREA in the HIPPOCAMPUS. Schaffer collaterals are important in memory, learning and activity-related NEURONAL PLASTICITY. HN - 2023(2015) BX - Schaffer Collateral MH - Schinus UI - D000093382 MN - B1.875.800.575.912.250.44.686 MS - A plant genus of the family ANACARDIACEAE. HN - 2023(2003) BX - Peppertree, Brazilian BX - Peppertree, California MH - Schlemm's Canal UI - D000092662 MN - A9.371.60.217.659.250 MS - A circular vascular-like structure in the anterior chamber of the eye bounded anterolaterally by the internal scleral sulcus and posteriorly by the trabecular meshwork. It is a part of a pathway where the AQUEOUS HUMOR from the ANTERIOR CHAMBER of the eye passes through the TRABECULAR MESHWORK, drains into the lumen of Schlemm’s canal, and subsequently returns to blood circulation into the veins of the SCLERA. HN - 2023 BX - Canal of Schlemm BX - Circular Channel, Limbis BX - Schlemm Canal BX - Scleral Venous Sinus BX - Sinus Venosus Sclerae MH - Secondary Data Analysis UI - D000094422 MN - E5.245.380.500 MN - E5.318.740.300.500 MN - H1.548.338.500 MN - L1.313.500.750.190.380.500 MN - N5.715.360.750.300.500 MN - N6.850.520.830.300.500 MS - Analysis or reanalysis of existing data collected by someone else usually for a different purpose. HN - 2023 MH - Secreted Frizzled-Related Proteins UI - D000094742 MN - D12.644.360.813 MN - D12.776.476.800 MS - Soluble and secreted frizzled-related proteins which function as modulators of WNT SIGNALING PATHWAY. HN - 2023 BX - sFRPS BX - Soluble Frizzled-Related Proteins FX - Frizzled Receptors MH - Seminal Proteins UI - D000094664 MN - D12.776.869 MS - Proteins found in semen. Seminal proteins are composed of SEMINAL PLASMA PROTEINS and SPERM PROTEINS. HN - 2023 BX - Semen Proteins MH - Septate Uterus UI - D000093665 MN - C12.50.351.500.852.667.375 MS - A congenital duplication of the UTERUS in which a septum is formed separating the uterus. The partitioning septum can also separate the CERVIX and VAGINA. HN - 2023 BX - Complete Septate Uteri BX - Complete Septate Uterus BX - Incomplete Septate Uterus BX - Septate Uterus and Vagina BX - Subseptate Uteri BX - Subseptate Uterus BX - Uterine Septum MH - Sigesbeckia UI - D000092664 MN - B1.875.800.575.912.250.100.808 MS - A plant genus of the family ASTERACEAE. It has been used in traditional herbal medicine and commonly referred to as St. Paul's wort. It produces an unpleasant smell and is sometimes referred to as pig pungent weed. HN - 2023 BX - Siegesbeckia BX - St. Paul's Wort MH - Single-Cell Gene Expression Analysis UI - D000092386 MN - E5.242.900.500 MN - E5.393.332.375 MS - Assaying the products of GENETIC TRANSCRIPTION in individual cells. AN - for entry term SINGLE-CELL RNA-SEQ, coordinate with RNA-SEQ HN - 2023 BX - Sc-RNAseq BX - ScRNA-seq BX - ScRNAseq BX - Single Cell Gene Expression Analysis BX - Single Cell Gene Expression Profiling BX - Single Cell Transcriptome Analysis BX - Single-Cell Gene Expression Profiling BX - Single-Cell RNA Seq BX - Single-Cell RNA-Seq BX - Single-Cell RNAseq BX - Single-Cell Transcriptome Analysis MH - Sinistral Portal Hypertension UI - D000094723 MN - C6.552.494.707 MS - Portal hypertension of the SPLENIC VEIN due to occlusion caused by pancreatic pathology such as PANCREATIC PSEUDOCYST and PANCRATIC CANCER. Sinistral portal hypertension is associated with GASTRIC VARICES and acute HEMATEMESIS. HN - 2023 BX - Left-Sided Portal Hypertension BX - Segmental Portal Hypertension MH - Sleep Duration UI - D000094362 MN - F2.830.855.703 MN - G11.561.803.189 MS - Total number of hours of sleep in a day. HN - 2023 BX - Sleep Quantity BX - Total Sleep Time MH - Social Group UI - D000092882 MN - I1.880.761.250 MN - N3.540.805 MS - A collection of two or more people who share a common identity as defined by beliefs, codes of conduct, CULTURE and SOCIAL NORMS. HN - 2023 BX - Social Unit MH - Socioeconomic Disparities in Health UI - D000093862 MN - I1.240.425.513.500.500 MS - Differences in health based on socioeconomic status. Socioeconomic-based health disparities often begins early in life due to various SOCIOECONOMIC FACTORS, e.g. social, economic and educational statuses that limit potential or realized access to resources for maintaining health. AN - SOCIAL DETERMINANTS OF HEALTH is available HN - 2023 BX - Economic Disadvantage in Health BX - Economic Disparities in Health BX - Economic Disparity in Health BX - Social Disadvantage in Health BX - Social Disparities in Health BX - Social Disparity in Health BX - Socioeconomic Disadvantage BX - Socioeconomic Disadvantage in Health BX - Socioeconomic Disparities BX - Socioeconomic Disparity MH - Sophora japonica UI - D000093846 MN - B1.875.800.575.912.250.401.734.750 MS - A member of the family FABACEAE, native to the FAR EAST and used in traditional medicine. Sophora japonica yellow flower bud and dried fruit extracts are rich in FLAVONOIDS, e.g., SOPHORICOSIDE and RUTIN. HN - 2023 BX - Chinese Scholar Tree BX - Japanese Pagoda Tree BX - Styphnolobium japonicum MH - Sophora flavescens UI - D000093845 MN - B1.875.800.575.912.250.401.734.500 MS - A Sophora species commonly used as medicinal herb and is main source of quinolizidine alkaloid MATRINES. It is a perennial with yellow flowers. HN - 2023 BX - Shrubby Sophora BX - Sophora angustifolia MH - South American People UI - D000094860 MN - M1.686.685 MS - People native to or inhabitants of SOUTH AMERICA including ARGENTINA; BOLIVIA; BRAZIL; CHILE; COLOMBIA; ECUADOR; FRENCH GUIANA; GUYANA; PARAGUAY; PERU; SURINAME; URUGUAY; and VENEZUELA. HN - 2023 BX - South Americans MH - South Asian People UI - D000094853 MN - M1.686.330.875.500 MS - People native to or inhabitants of SOUTHERN ASIA including AFGHANISTAN; BANGLADESH; BHUTAN; INDIA; MALDIVES; NEPAL; PAKISTAN and SRI LANKA HN - 2023 BX - Asians, Southern BX - South Asian Person BX - South Asians BX - Southern Asian People BX - Southern Asian Person BX - Southern Asians MH - Southeast Asian People UI - D000095224 MN - M1.686.330.750 MS - People native to or inhabitants of SOUTHEASTERN ASIA including BORNEO; BRUNEI; CAMBODIA; INDONESIA; LAOS; MALAYSIA; the MEKONG VALLEY; MYANMAR (formerly Burma), the PHILIPPINES; SINGAPORE; THAILAND; and VIETNAM. It includes people native or inhabitants of the MEKONG VALLEY. HN - 2023; for BURMESE use ASIANS 2013-2022; for CAMBODIANS use ASIANS 2013-2022; for THAI use ASIANS 2013-2022; for VIETNAMESE use ASIANS 2013-2022 BX - Southeast Asians BX - Southeastern Asian People BX - Southeastern Asians MH - Southern African People UI - D000094847 MN - M1.686.254.750.875 MS - People native to or inhabitants of SOUTHERN AFRICA including ANGOLA; BOTSWANA; EWATINI; LESOTHO; MALAWI; MOZAMBIQUE; NAMIBIA; SOUTH AFRICA; ZAMBIA; and ZIMBABWE. HN - 2023 BX - Southern African Person BX - Southern Africans MH - Sperm Proteins UI - D000094323 MN - D12.776.869.500 MS - Proteins found in sperm. Sperm-specific proteins have important roles in FERTILIZATION including SPERM MOTILITY and SPERM-OVUM INTERACTIONS. Sperm-specific proteins are also important for early EMBRYO DEVELOPMENT. HN - 2023 BX - Sperm Specific Proteins BX - Sperm Tail Proteins BX - Sperm-Specific Proteins BX - Spermatozoa Proteins MH - Sub-Saharan African People UI - D000094844 MN - M1.686.254.750 MS - People native to or inhabitants of SUB-SAHARAN AFRICA including ANGOLA; BENIN; BOTSWANA; BURKINA FASO; BURUNDI; CABO VERDE; CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; COTE D'IVOIRE; DEMOCRATIC REPUBLIC OF THE CONGO; DJIBOUTI; EQUATORIAL GUINEA; ERITREA; ESWATINI; ETHIOPIA; GABON; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; KENYA; LESOTHO; LIBERIA; MALAWI; MALI; MAURITANIA; MOZAMBIQUE; NAMIBIA; NIGER; NIGERIA; RWANDA; SAO TOME AND PRINCIPE; SENEGAL; SIERRA LEONE; SOMALIA; SOUTH AFRICA; SOUTH SUDAN; SUDAN; TANZANIA; TOGO; UGANDA; ZAMBIA; and ZIMBABWE. HN - 2023 BX - Sub-Saharan African Person BX - Sub-Saharan Africans BX - Sub-Saharans MH - Subgenomic RNA UI - D000094762 MN - D13.444.735.544.713 MN - D13.444.735.828.500 MS - RNA that results from VIRUS REPLICATION of partial genomic regions. The process may involve specific internal transcriptional initiation and termination sites. AN - do not confuse sgRNA (SUBGENOMIC RNA) with sgRNA (SINGLE-GUIDE RNA see RNA, GUIDE, CRISPR-Cas SYSTEMS) HN - 2023 BX - sgmRNA BX - Subgenomic Messenger RNA BX - Subgenomic mRNA BX - Subgenomic Replicon BX - Subgenomic Replicon RNA BX - Subgenomic RNA Replicon FX - CRISPR-Cas Systems MH - Suicide Prevention UI - D000092864 MN - F1.145.126.980.875.225 MN - I1.880.735.856.225 MN - N2.421.726.843 MS - Specific strategies for averting suicides. These include mental HEALTH PROMOTION and monitoring PSYCHOLOGICAL WELL-BEING and other intervention programs targeting susceptible individuals. HN - 2023 BX - Suicide Awareness MH - Symbiont Induced Cytoplasmic Incompatibility UI - D000094402 MN - G6.462.95 MN - G16.527.200.95 MS - A naturally occurring reproductive phenomenon of INVERTEBRATES in which only certain combination of crosses result in viable embryos due to incompatibility between sperm and egg cells that is caused by differences in intracellular parasites (symbionts). For example, a maternally inherited symbiont bacteria, e.g., WOLBACHIA, induces changes in sperm of the host, causing mitotic defects in the fertilized embryo only in crosses between symbiotic males and females harboring a different or no symbiont. HN - 2023 MH - Synthetic Cathinone UI - D000094982 MN - D2.522.818.890 MS - A propiophenone derivative chemically related to cathinone, a substance found in the KHAT plant. HN - 2023 BX - (3,4)-Methylenedioxypyrovalerone BX - 3,4-Methylenedioxypyrovalerone BX - MDPV BX - MDPV Compound BX - Methylenedioxypyrovalerone BX - Psychoactive Bath Salts BX - Synthetic Cathinones MH - T-Cell Exhaustion UI - D000094383 MN - G12.819 MS - Progressive deterioration of T-cell function due to chronic antigen stimulation and inflammatory signals, e.g., CHRONIC INFECTION and CANCER. T-cell exhaustion is characterized by weakened immune system, e.g., dysfunctional MEMORY T CELLS differentiation and EPIGENETIC REPRESSION of IMMUNOLOGIC MEMORY effector functions. HN - 2023 BX - T-Cell Senescence FX - Lymphocyte Depletion MH - Tattoo Removal UI - D000092945 MN - E4.14.520.775 MS - Procedures to remove a tattoo. They may include laser surgery, excisional surgery, dermabrasion, or application of topical agents. HN - 2023 MH - Theory of Planned Behavior UI - D000092963 MN - E5.599.695.775 MN - F2.985 MS - The construct in which intentions to perform behaviors of different kinds can be predicted with high accuracy from attitudes toward the behavior, subjective norms, and perceived behavioral control; and these intentions, together with perceptions of behavioral control, account for considerable variance in actual behavior. (from Ajzen, Organizational Behavior and Human Decision Processes, V.50, Issue 2, p.179-211.) HN - 2023 BX - Planned Behavior Theory BX - Theory of Reasoned Action MH - Thymic Stromal Lymphopoietin UI - D000094632 MN - D12.644.276.374.656 MN - D12.776.467.374.656 MN - D23.529.374.656 MS - A pleiotropic cytokine involved in INFLAMMATION and immunoregulation. Thymic stromal lymphopoietin can activate MAST CELLS; DENDRITIC CELLS; and T-LYMPHOCYTES, and is produced by various cell types, including epithelial and dendritic cells.. HN - 2023 BX - TSLP Cytokine MH - Tibial Plateau Fractures UI - D000092463 MN - C26.404.525.500 MN - C26.404.875.500 MN - C26.558.554.625.500 MN - C26.558.857.500 MS - Fractures in the proximal portion of the TIBIA which acts as articular surface in the KNEE. They are often associated with knee ligament injuries (e.g., ACL TEARS). HN - 2023 BX - Bicondylar Tibial Plateau Fracture BX - Bicondylar Tibial Plateau Fractures BX - Lateral Tibial Plateau Fracture BX - Lateral Tibial Plateau Fractures BX - Medial Tibial Plateau Fracture BX - Medial Tibial Plateau Fractures MH - Tobacco Control UI - D000092843 MN - I1.655.500.608.400.825 MN - I1.880.604.825.608.400.825 MN - N3.623.500.608.428.825 MS - Policies, regulations and programs implemented to encourage SMOKING PREVENTION and reduce TOBACCO USE DISORDER by various measures, e.g., TOBACCO INDUSTRY regulation, SMOKE-FREE POLICY and SMOKE CESSATION programs . HN - 2023 BX - Smoking Control Policy BX - Smoking Policy BX - Smoking Regulation BX - Tobacco Policy BX - Tobacco Program BX - Tobacco Regulation MH - Traditional Medicine Practitioners UI - D000095083 MN - M1.526.485.882 MN - N2.360.858 MS - Health personnel using systems of medicine based on cultural beliefs and practices handed down from generation to generation, including mystical and magical rituals (SPIRITUAL THERAPIES); TRADITIONAL MEDICINE; PHYTOTHERAPY; HERBAL MEDICINE; and other treatments which may not be explained by modern medicine. HN - 2023 BX - African Witch Doctor BX - Alternative Medicine Practitioners BX - CAM Practitioners BX - Complementary and Alternative Medicine Practitioners BX - Complementary Health Practitioners BX - Complementary Medicine Practitioners BX - Ethnobotanists BX - Herbalists BX - Indigenous Medicine Practitioners BX - Medicine Men BX - Phytotherapists BX - Shaman BX - Shamans BX - Traditional Healers BX - Traditional Health Practitioners BX - Witch Doctor, African FX - Medicine, African Traditional FX - Medicine, Traditional FX - Shamanism MH - Trained Immunity UI - D000094384 MN - G12.450.564.904 MS - Ability of the INNATE IMMUNITY system to form IMMUNOLOGIC MEMORY and provide enhanced defense against subsequent secondary infections. In trained immunity, long-term adaptation of innate immune cells occurs through EPIGENETIC PROCESSES and metabolic CELLULAR REPROGRAMMING to form long term immunologic memory. HN - 2023 BX - Innate Immune Memory BX - Innate Trained Immunity BX - Trained Innate Immunity MH - Transurethral Resection of Bladder UI - D000094463 MN - E4.950.774.790 MS - Surgical removal of tumor in the BLADDER with resectoscope inserted through the URETHRA. HN - 2023 BX - Transurethral Resection of Bladder Tumor BX - TURBT Transurethral Resection of Bladder Tumor MH - Tuberculosis, Extrapulmonary UI - D000092225 MN - C1.150.252.410.40.552.846.617 MS - MYCOBACTERIUM infections of organs other than the lung. HN - 2023 BX - Extra-Pulmonary Tuberculosis BX - Extrapulmonary Tuberculosis MH - Tympanosclerosis UI - D000092163 MN - C9.218.951 MS - Calcification of the TYMPANIC MEMBRANE and MIDDLE EAR most often associated with chronic OTITIS MEDIA. HN - 2023(2013) BX - Intratympanic Tympanosclerosis BX - Tympanic Calcification MH - Tyrosine Protein Kinase Inhibitors UI - D000092004 MN - D27.505.519.389.755.875 MS - Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. HN - 2023 BX - TKI Tyrosine Kinase Inhibitors BX - Tyrosine Kinase Inhibitor BX - Tyrosine Kinase Inhibitors MH - Ultrasonography, Carotid Arteries UI - D000092262 MN - E1.370.350.850.708 MS - Ultrasound imaging of the CAROTID ARTERIES to measure their morphological components such as arterial wall shape and thickness; ATHEROSCLEROTIC PLAQUE; and STENOSIS. BLOOD CIRCULATION in the carotid is visualized via DOPPLER ULTRASONOGRAPHY. HN - 2023 BX - Carotid Artery Ultrasonography BX - Carotid Ultrasonography BX - Carotid Ultrasound BX - Ultrasonography of Carotid Arteries BX - Ultrasonography of Carotid Artery BX - Ultrasonography, Carotid Artery FX - Carotid Arteries MH - Urinary Sediment Analysis UI - D000095025 MN - E1.370.225.124.810.500 MN - E1.370.390.810.500 MN - E5.200.124.810.500 MS - Microscopic visualization and/or chemical analysis of the sediments in URINE. HN - 2023 MH - Urticaria, Solar UI - D000092130 MN - C17.800.600.825 MN - C17.800.862.945.533.500.750 MN - C20.543.480.904.533.500.750 MN - C23.550.291.500.360.500.750 MS - Chromophore-dependent photodermatosis triggered by UV and visible light. HN - 2023 BX - Solar Urticaria MH - Uterine Didelphys UI - D000093642 MN - C12.50.351.500.852.667.500 MS - An abnormality in which the MULLARIAN DUCTS do not properly join to form a single uterus during embryological development instead resulting in complete duplication of uterine horns and duplication of the cervix. Double uterus is associated with double cervix and vagina and sometimes renal agenesis. HN - 2023 BX - Didelphic Uteri BX - Double Uterus with Imperforated Vagina BX - Uterus Didelphys with Imperforate Vagina BX - Uterus Didelphys with Imperforated Vagina MH - Uterine Duplication Anomalies UI - D000093662 MN - C12.50.351.500.852.667 MN - C12.50.351.875.940 MN - C12.200.706.940 MN - C12.800.940 MN - C16.131.939.957 MS - A group of anomalies in which the UTERUS is duplicated due to abnormal fusion of the MULLERIAN DUCT during embryonic development. HN - 2023 BX - Double Uterus BX - Double Womb MH - Value-Based Health Care UI - D000093683 MN - N4.590.374.950 MN - N5.300.915 MS - Health system model designed to maximize value for patients. Value based healthcare often emphasizes better patient outcomes for healthcare cost through best practices (e.g., preventive screening, quality incentives). HN - 2023 BX - Value Based Health Care BX - Value Based Healthcare BX - Value-Based Healthcare BX - VBHC Value Based Healthcare MH - Venom Hypersensitivity UI - D000092422 MN - C20.543.480.952 MS - Allergic reaction to venoms in insect bites and stings that is triggered by the immune system (i.e., HISTAMINE RELEASE). HN - 2023 BX - Allergy, Venom BX - Arthropod Venom Allergy BX - Arthropod Venom Hypersensitivity BX - Bee Sting Allergy BX - Bee Sting Anaphylaxis BX - Bee Sting Hypersensitivity BX - Fire Ant Sting Allergy BX - Fire Ant Sting Hypersensitivity BX - Honeybee Venom Allergy BX - Hornet Sting Allergy BX - Hornet Sting Hypersensitivity BX - Hypersensitivity, Venom BX - Insect Bite Papular Urticaria BX - Insect Sting Allergy BX - Insect Venom Allergy BX - Jellyfish Sting Allergy BX - Jellyfish Sting Hypersensitivity BX - Venom Allergy BX - Wasp Sting Allergy BX - Wasp Sting Hypersensitivity MH - Ventricular Outflow Obstruction, Left UI - D000092242 MN - C14.280.955.875 MS - Occlusion of the outflow tract in the LEFT VENTRICLE of the heart. HN - 2023(1988) BX - Dynamic Left Ventricular Outflow Tract Obstruction BX - Dynamic LVOT Obstruction BX - Left Ventricular Outflow Tract Obstruction BX - LVOT Obstruction MH - Ventricular Outflow Obstruction, Right UI - D000092243 MN - C14.280.955.937 MS - Occlusion of the outflow tract in the RIGHT VENTRICLE of the heart. HN - 2023 BX - Dynamic Right Ventricular Outflow Tract Obstruction BX - Dynamic RVOT Obstruction BX - Right Ventricular Outflow Tract Obstruction BX - RVOT Obstruction MH - Volume Electron Microscopy UI - D000094443 MN - E1.370.350.515.402.812 MN - E5.595.402.812 MN - L1.224.308.705 MS - Electron microscopy techniques designed to reconstruct 3-D images at micrometer volume scales at nanometer (nm) level resolutions. Volume electron microscopy uses various techniques to render, segment and reconstruct 3-D images from stacked sequential 2-D images of incremental z-planes. HN - 2023 BX - FIB-SEM BX - Focused Ion Beam Scanning Electron Microscopy BX - Focused Ion Beam SEM BX - SBF-SEM BX - Serial Block-Face Scanning Electron Microscopy BX - Serial Block-Face SEM BX - Serial Sectioning TEM BX - Serial Sectioning Transmission Electron Microscopy BX - ssTEM BX - vEM Volume Electron Microscopy BX - Volume EM MH - West African People UI - D000094848 MN - M1.686.254.750.937 MS - People native to or inhabitants of WEST AFRICA (western part of the sub-Saharan Africa) including BENIN; BURKINA FASO; CABO VERDE; IVORY COAST; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; TOGO and CAPE VERDE ISLANDS. HN - 2023 BX - West African Person BX - West Africans BX - Western African People BX - Western African Person BX - Western Africans MH - West Asian People UI - D000094865 MN - M1.686.330.875 MS - People native to or inhabitants of WESTERN ASIA including BANGLADESH; BHUTAN; INDIA; IRAN; IRAQ; ISRAEL; JORDAN; KUWAIT; LEBANON; MALDIVES; NEPAL; OMAN; PALESTINIAN TERRITORIES; PAKISTAN; QATAR; SAUIDI ARABIA; SRI LANKA; SYRIA; TURKEY; UNITED ARAB EMIRATES and YEMEN. HN - 2023 BX - Asians, Western BX - West Asian Person BX - West Asians BX - Western Asian People BX - Western Asian Person BX - Western Asians MH - White UI - D000095223 MN - M1.686.477.625.594.812 MN - M1.686.877.500 MS - A person having origins in any of the white racial groups of Europe, the Middle East and North Africa (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. HN - 2023; use CAUCASIAN RACE 1963-1977, WHITES 1978-2003, CAUCASOID RACE 1978-2003, EUROPEAN CONTINENTAL ANCESTRY GROUP 2004-2021, WHTIES 2022 BX - Whites MH - Wildlife Trade UI - D000094462 MN - I3.915 MS - Commerce of non-domesticated WILD ANIMALS or plants. Wildlife trade, particularly illegal trades, threaten ECOSYSTEMS and drives up SPECIES EXTINCTION. It also increases chance of emerging ZOONOSES. HN - 2023 BX - Wildlife Poaching BX - Wildlife Trafficking FX - Crime MH - Working Conditions UI - D000092922 MN - N1.824.245.925.500 MN - N4.452.677.975.500 MS - Conditions of a WORKPLACE such as weather (e.g., indoor or outdoor), safety (e.g., exposure to hazardous materials), environment and workplace culture and management style. HN - 2023 BX - Work Environment BX - Working Condition BX - Working Environment BX - Workplace Condition BX - Workplace Conditions BX - Workplace Environment MH - Wrist Fractures UI - D000092503 MN - C26.88.906.500 MN - C26.404.968 MS - Fractures of the CARPAL BONES, the distal ULNA and/or RADIUS at the WRIST. HN - 2023 BX - Distal Forearm Fractures BX - Distal Radius and Ulna Fractures BX - Distal Radius Fractures BX - Distal Ulna and Radius Fractures BX - Distal Ulna Fractures BX - Radial Styloid Fractures BX - Smith Fracture